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In recent years, semiconductor quantum dots (QDs) have arisen as a new class of 
fluorescent probes that possess unique optical and electronic properties well-suited for 
single-molecule imaging of dynamic live cell processes. Nonetheless, the large size of 
conventional QD-ligand constructs has precluded their widespread use in single-molecule 
studies, especially on cell interiors. A typical QD-ligand construct can range upwards of 
35 nm in diameter, well exceeding the size threshold for cytosolic diffusion and posing 
steric hindrance to binding cell receptors.  
The objective of this research is to develop tagging strategies that allow QD-
ligand conjugates to specifically bind their target proteins while maintaining a small 
overall construct size. To achieve this objective, we utilize the HaloTag protein (HTP) 
available from Promega Corporation, which reacts readily with a HaloTag ligand (HTL) 
to form a covalent bond. When HaloTag ligands are conjugated to size-minimized 
multidentate polymer coated QDs, compact QD-ligand constructs less than 15 nm in 
diameter can be produced. These quantum dot-HaloTag ligand (QD-HTL) conjugates can 
then be used to covalently bind and track cellular receptors genetically fused to the 
HaloTag protein.  
In this study, size-minimized quantum dot-HaloTag ligand conjugates are 
synthesized and evaluated for their ability to bind specifically to purified and cellular 
HTP. The effect of QD-HTL surface modifications on different types of specific and 
nonspecific cellular binding are systematically investigated. We show that ligand length, 
ligand valency, polyethylene glycol (PEG) length, and PEG density are all important 
 xix 
factors that govern QD-HTL binding specificity. Once these QD surface parameters are 
optimized, QD-HTLs are indeed capable of specifically binding HaloTag protein. Finally, 
these QD-HTL conjugates are utilized for single-molecule imaging of dynamic live cell 
processes. By applying QD-HTLs to the tracking of cellular β1 integrin-HaloTag fusion 
proteins, we show that QD-HTLs convey accurate information about cellular protein 
dynamics while providing far greater luminescence and photostability than fluorescent 
dyes.  
This work is significant because it is the first to synthesize size-minimized QD-
HTL probes that bind specifically to HTP and to apply them for single-molecule imaging 
in living cells. Our results show that size-minimized QD-HTLs exhibit great promise as 
novel imaging probes for live cell imaging, allowing researchers to visualize cellular 








Ever since A.H. Coons developed the first methods to conjugate proteins to 
fluorophores in 1941 [1], and green fluorescent protein was successfully purified from 
Aequorea Victoria in the 1960s [2], fluorescent dyes and proteins have revolutionized the 
field of biology. Fluorescent dyes and proteins have since become instrumental tools for 
visualizing the dynamic behavior of biomolecules within living cells using light 
microscopy. Traditionally, researchers have studied receptor pathways using bulk-
averaged measurements derived from whole cell populations of receptors labeled with 
fluorescent dyes or proteins. In reality, however, individual receptor processes are highly 
heterogeneous and can deviate greatly from ensemble behavior [3]. 
In recent years, single-molecule imaging has emerged as a powerful, highly 
sensitive method capable of providing a wealth of information normally obscured by 
ensemble averaging. The utility of single-molecule imaging can be illustrated by 
considering a classic example of a population of molecular beacons, half of which are 
quenched (closed), and half of which are fluorescent (open). In this example, an ensemble 
spectrum would not be able to distinguish whether 50% of the molecular beacon 
population is fully quenched, or whether 100% of the population is half-quenched. 
Single-molecule detection would not only provide this information, but would also allow 
the researcher to monitor the spatial and temporal resolution of the opening and closing 
[4].   
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Fluorescence imaging has always been an attractive option for single-molecule 
detection due to the ease of detecting a bright signal against a dark background. However, 
single-molecule imaging with fluorescent dyes and proteins is difficult to accomplish for 
several reasons. Foremost, it is technically challenging to achieve a good signal-to-noise 
ratio when tracking a solitary fluorophore in a complex biological environment. The 
signal of a single fluorophore can be greatly overpowered just by the Raman scatter from 
surrounding solvent molecules. For instance, the Raman scatter alone from 1 ml of pure 
water is already 10
10
 fold greater than the signal from one Rhodamine Green molecule. 
The background noise is further exacerbated by cellular autofluorescence and complex 
biological liquids in live cell applications. To diminish the effects of light scattering, a 
reduction in the surrounding volume (to usually at least 1 femtoliter) is necessary to 
obtain adequate signal from a single fluorophore [4].  
As a means of reducing the detection volume to achieve higher signal-to-noise 
ratio, complex optical configurations such as total internal reflection microscopy 
(TIRFM) are commonly applied. To achieve this reduced volume, TIRFM uses an 
evanescent field, which limits the height of detection to ~100-200 nm [4-6]. One 
disadvantage of TIRFM is that imaging is consequently limited to close proximity of the 
cell membrane. Naturally, this would not be ideal for intracellular single-molecule 
tracking. Other optical setups for single-molecule fluorescence imaging include confocal 
and two-photon microscopy setups [4, 7], along with more recent super-resolution 
imaging techniques [8, 9]. Even with these special optical setups, fluorescent single-
molecule imaging remains challenging due to the poor photostability of traditional 
fluorophores. Fluorescence emission from organic dyes and proteins decays very rapidly, 
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typically bleaching within 10 s, preventing single molecules from being tracked for long 
periods of time [10-12].  
In recent years, inorganic quantum dots (QDs) have emerged as a promising 
alternative to traditional organic fluorophores, with many properties well-suited for 
single-molecule imaging. QDs have 10-100x higher extinction coefficients and 100-
1000x greater photostability than fluorescent dyes and proteins. As a result, special 
optical setups are not needed to perform single-molecule imaging with QDs, and QDs can 
be tracked under a standard epifluorescence microscope for hours without 
photobleaching. [13-15].  
Quantum dots have already found many promising applications in biology and 
medicine, including in vivo animal imaging [16-18], medical diagnostics [19-22], and 
cellular imaging [23, 24]. In the latter category, QDs have been used to track several 
types of cell membrane receptors, including G-protein coupled receptors [25], receptor 
tyrosine kinases [26, 27], and integrins [28, 29] through endocytic pathways. QDs have 
been delivered into cell cytoplasm by a variety of chemical and mechanical methods [30], 
and the subsequent interactions of the QD with the active transport machinery of the cell 
have been studied [31, 32]. Additionally, QDs have been coated with endosome-
disrupting coatings to investigate potential mechanisms of nanoparticle delivery and 
release into cells [33].   
However, applications of quantum dots in live cell imaging have remained limited 
because of the large size and cumbersome tagging strategies of traditional QD probes. 
The conventional approach for QD tagging is to conjugate the QD to an antibody that has 
a specific affinity for a protein of interest. Due the large QD surface area available for 
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coupling, multiple antibodies often bind each nanoparticle, resulting in a bulky structure 
capable of crosslinking several target proteins. Due to the stochastic nature of chemical 
conjugation, QDs often contain varied amounts of conjugated antibody on their surfaces, 
which may be attached in any number of different active or inactive geometric 
orientations. A typical commercial QD ranges from 15-35 nm in hydrodynamic diameter, 
and the presence of each surface protein or antibody can contribute an additional 4-15 nm 
to the total size. Altogether, these factors work together to produce a total QD construct 
that can reach up to 50 nm in diameter [34]. These bulky constructs pose steric hindrance 
to binding cell receptors and can crosslink multiple receptors, preventing the imaging of 
single molecules. They also are too large to diffuse freely inside crowded cellular regions 
such as the cell cytoplasm. As a result, QD imaging remains largely limited to the 
surfaces of cell membranes.   
In addition to increasing QD probe size, conventional QD targeting approaches 
are less than ideal for single-molecule tracking. During cellular imaging, it is critical to 
insure that the QD-targeting ligand construct remains attached to the protein of interest. 





M) and may dissociate from proteins of interest during prolonged 
tracking studies [35].  
In this thesis, we seek to address the existing problems with QD size and QD 
targeting so that quantum dots can obtain greater applicability in dynamic live cell 
imaging. Recently, several new tagging strategies have emerged that allow fluorophores 
to bind covalently to their targets [36-39]. Many of these techniques have been previously 
used with dyes, but very few have yet been implemented or optimized with QDs. These 
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tagging strategies provide novel approaches for tracking cellular proteins, and have the 
potential to alleviate many current disadvantages associated with traditional QD probes.  
1.2 Dissertation Objective 
The focus of this research is to develop QD-tagging strategies that allow QD-
ligand conjugates to specifically bind their target proteins while still maintaining a small 
overall construct size. Our long-term goal is to engineer an ideal QD probe that can be 
successfully used for dynamic single-molecule imaging of cellular processes in living 
cells. The rationale is that small QD-targeting ligand constructs are necessary to diffuse 
in cell interiors, and that a covalent strategy is ideal for preventing dissociation of the QD 
from the protein of interest. We propose to utilize the HaloTag protein (HTP), a 33 kDa 
protein commercially available from Promega Corporation that reacts readily with a 
chloroalkane moiety, or “HaloTag ligand” (HTL), to form a covalent bond [40]. We 
hypothesize that QDs displaying surface HaloTag ligands will retain the ability to 
covalently bind cellular proteins of interest genetically fused to a HaloTag protein, 
thereby providing a new strategy for implementing QDs for single-molecule imaging. 
1.3 Dissertation Organization 
This dissertation is organized as follows:  
In this chapter we have described the importance of live cell imaging in 
biomedical research and provided an overview of the applications of QDs in live cell 
imaging.  
Chapter 2 will provide background information on the physical properties of 
quantum dots and their advantages over fluorescent dyes for live cell imaging. We will 
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discuss traditional methods for QD synthesis and bioconjugation along with opportunities 
for improvement in the next generation of QDs.  
Chapter 3 will discuss the benefits of size-minimized QDs for cellular imaging 
and highlight some of the current research strategies to reduce quantum dot size and 
improve tagging strategies. We will present our own research strategy in choosing to use 
size-minimized multidentate-polymer coated QDs with HaloTag ligands for the purpose 
of engineering a QD-based probe for dynamic live cell imaging.  
In Chapter 4 we discuss the procedures for synthesizing QD-HaloTag ligand 
conjugates and characterize their ability to bind purified HaloTag proteins in vitro.  
In Chapter 5 we evaluate the ability of QD-HaloTag ligand conjugates to 
specifically bind cellular targets. 
In Chapter 6 we investigate the use of QD-HaloTag ligand conjugates for single-
molecule imaging of dynamic cellular processes. 
Finally, in Chapter 7, we summarize the major findings from our study and 
present future opportunities for application of this technology.  
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 CHAPTER 2 
QUANTUM DOTS FOR LIVE CELL IMAGING 
 
2.1 Introduction 
Nanotechnology is an exciting field with tremendous potential to revolutionize 
human life by creating new technologies in electronics, energy production, and medicine. 
It is a multidisciplinary field that uses chemistry, material science, and engineering to 
manipulate materials with one or more dimensions sized less than 100 nanometers. In 
particular, the field of biomedicine is poised to greatly benefit from nanotechnology, 
since several cellular structures including proteins and DNA fall within the “nano” size 
regime [41].  
Recent advances in nanotechnology have led to the development of various novel 
structures such as magnetic nanoparticles, carbon nanotubes, and quantum dots. Due to 
their small size and large surface area-to-volume ratio, nanostructures exhibit several 
unique properties compared to bulk materials. When attached to biological targeting 
ligands, nanoparticles have the potential to bind to cellular structures, making them good 
candidates for medical diagnostics and therapy [42].  
In particular, quantum dots are an exciting class of semiconductor nanoparticles 
that exhibit the special property of intense fluorescence. Quantum dots have already 
found widespread utility in several applications including solar energy conversion [43, 
44], light emitting diodes [45], and quantum computing [46]. In this chapter, we will 
discuss how the intense fluorescence of QDs can be channeled as a useful tool for 
biomedical imaging. We will describe several methods of attaching biological targeting 
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ligands to QDs for developing novel biological imaging probes. Finally, we will focus on 
the specific application of these probes in the biological imaging of cellular proteins in 
living cells.  
2.2 Properties of Quantum Dots 
Physical Characteristics of Quantum Dots 
Quantum dots are fluorescent semiconductor nanocrystals that exhibit special 
optical and electronic properties due to the “quantum confinement effect”. They are 
commonly composed of II-VI (e.g. CdS, CdSe, CdTe), III-V (e.g. InAs, InP), or IV-VI 
(e.g. PbSe, PbS) semiconductor materials [14]. Figure 2.1 illustrates the difference 
between semiconductor quantum dots and bulk semiconductors. As shown in the left side 
of Figure 2.1, bulk semiconductors are characterized by a valence band (blue) and a 
conduction band (white) separated by a characteristic energy bandgap. When a bulk 
semiconductor is excited by a photon, an electron leaves the valence band and enters the 
conduction band, leaving behind a positively charged hole in the valence band. The 
electron and hole form a pair called an exciton, and the physical distance of separation 
between them is known as the material’s exciton Bohr radius. For bulk semiconductors, 
the exciton Bohr radius is typically ~2 to 20 nm, much smaller than the size of the 
material. At any point in time, the electron may relax and recombine with the hole in the 











Figure 2.1. Quantum confinement effect of semiconductors. Quantum confinement of 





When a semiconductor material becomes confined in size in three dimensions 
such that its size is smaller than its characteristic exciton Bohr radius, its bandgap energy 
increases and its energy levels become discretized (Figure 2.1 right). As a result, the 
nanoparticle’s wavelength becomes highly dependent upon its size. The greater the 
degree of confinement and the smaller the nanocrystal is in size, the higher its bandgap 
energy becomes. Since energy is inversely proportional to wavelength, smaller quantum 
dots emit at shorter wavelengths while larger quantum dots emit at longer wavelengths. 
As such, the color of the QD can be modulated by size and material composition to 
produce nanoparticles with fluorescence emission spanning the ultraviolent, entire visible 
light, and near-infrared ranges. Figure 2.2 a and b depict the emission wavelengths 




Figure 2.2. Quantum dot optical properties. (a) Six different sizes of cadmium selenide 
QDs under UV illumination and (b), their corresponding fluorescence emission spectra. 
(c) Absorption (blue) and emission (red) spectra of QDs compared with traditional 




Comparison of Quantum Dots with Fluorescent Dyes 
QDs have several desirable properties that make them exceptional candidates for 
single-molecule imaging compared to traditional organic fluorophores. Due to their large 
absorption cross sectional areas, QDs exhibit intrinsically high signal brightness. With 






, they are 
on average 10-100x brighter than fluorescent dyes and proteins. The long fluorescence 
lifetimes (20-50 ns) of QDs are also advantageous, as well as their excellent resistance 
toward photobleaching [3, 13-15, 47]. In contrast with fluorescent dyes, which bleach 
almost immediately upon exposure to light, QDs are able to maintain constant 
fluorescence intensity for hours under UV illumination [11, 48].  
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As depicted in Figure 2.2c, all QDs possess broad absorption bands and narrow 
symmetric emission bands. One important consequence is that a single light source can 
be used to concurrently excite multiple QDs with different emission wavelengths, 
facilitating the simultaneous detection of several biomarkers in multiplexed assays and 
multi-color tracking experiments [21, 49]. In contrast, multiplexing is difficult to achieve 
with fluorescent dyes and proteins due to their relatively narrow, specific absorption 
bands. Nonetheless, QDs do have their disadvantages. Figure 2.2c shows that QDs 
(typically 10-40 nm) are an order of magnitude larger than organic dyes (typically < 1 
nm) and fluorescent proteins (typically ~5 nm), such that steric effects and nonspecific 
interactions must be taken into consideration when evaluating probe performance [3].  
As detailed in the next section, the large size of QDs partially stems from 
limitations in traditional QD synthesis and coating strategies, and can be further 
exacerbated by the choice of bioconjugation strategy. In the meantime, our lab and others 
have devoted much research to developing improved synthetic techniques for producing 
QDs with smaller nanocrystalline cores and organic surface coatings, along with reduced 
nonspecific effects [50-55]. 
2.3 Quantum Dot Probe Development 
Quantum Dot Synthesis 
Quantum dots were first synthesized by Alexander Ekimov and Alexei Efros in 
1982 by growing nanocrystals in glass matrices [56, 57]. Since then, a wide variety of 
approaches have been developed to synthesize QDs in organic solvents, aqueous 
solutions, and on solid substrates. QDs have been fabricated using “top-down” 
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approaches such as lithography [58], and “bottom-up” approaches such as chemical vapor 
deposition [59] and molecular beam epitaxy [60, 61].  
The most common procedure for producing high quality QDs is to synthesize 
colloidal suspensions of QDs using semiconductor precursors and organic surfactants. 
The fundamental procedure for colloidal QD synthesis was established in 1993, when 
Bawendi and coworkers developed a method for creating extremely monodisperse QDs 
composed of cadmium sulfide (CdS), cadmium selenide (CdSe), and cadmium telluride 
(CdTe) [62]. In a typical synthesis of CdSe QDs, a room-temperature Se precursor is 
quickly injected into a hot solution containing a Cd precursor and an organic surfactant 
under inert atmosphere. Organic surfactants commonly employed in this synthesis 
include alkyl phosphines, alkyl phosphine oxides, or alkylamines (e.g. trioctylphosphine, 
trioctylphosphine, hexadecylamine). At high temperature around 300 
0
C, monomers of 
the semiconductor precursors react quickly and nucleate to form CdSe nanocrystals. The 
organic surfactant serves as a coordinating ligand that binds to the surface of the 
nanocrystal and controls its rate of growth. Once the desired nanocrystal size and 
wavelength is achieved, the entire solution is quickly cooled to room temperature to 
prevent further growth.  
Although synthesis of the QD is completed at this point, many researchers will 
choose to cap the QD core with another “shell” layer to enhance the luminescence 
efficiency and photostability of the QD. Because nanocrystals contain a large surface area 
to volume ratio, a large number of atoms are exposed to the surface of the QD. Some 
molecular orbitals of the surface atoms are bonded to other atoms, while other orbitals 
remain either unbonded or weakly bonded with organic coordinating ligands. Because the 
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bond strength between the surface atom and the coordinating ligand is much weaker than 
the bond strength between atoms, ligand desorption can occur over time, creating 
unbonded orbitals. Since unbonded and incompletely bonded “dangling” orbitals can 
quench QD fluorescence, the additional growth of a semiconductor shell with a larger 
bandgap helps to provide electronic insulation to the atoms on the surface of the core.   
Zinc sulfide (ZnS) is a popular choice for a shell material due to its enhanced 
resistance to oxidation and greater bond strength with coordinating ligands compared to 
cadmium. To cap a CdSe with ZnS, the CdSe are first purified from unreacted Cd and Se 
precursors. In a similar procedure as before, Zn and S precursors are injected into a 
solution containing CdSe QDs and organic coordinating ligands. This time however, the 
temperature is reduced to ~160 - 220
 0
C and the precursors are slowly added. These 
conditions help prevent nucleation of ZnS nanocrystals, and instead favor growth of the 
ZnS shell on the CdSe core.  
Unfortunately, direct growth of the ZnS shell on the CdSe core produces high 
interfacial strain due to a large difference in lattice constants between the core and shell 
materials. This interfacial strain can result in the formation of defect sites, thereby 
decreasing the quantum efficiency of the QD. Several researchers have found that the 
high strain can be alleviated by including intermediate shell layers with successively 
changing lattice constants [63-65]. As a result, it is very common to find QDs with varied 
compositions such as CdSe(CdS/ZnS) or CdSe(ZnSe/ZnS).  
In 2003, Peng and coworkers showed that high quality core/shell nanocrystals can 
be formed using “successive ion layer adsorption and reaction” (SILAR), a procedure 
that forms the fundamental basis of many QD capping protocols used today [66]. The 
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hallmark of this procedure is that alternating additions of shell precursors can be used to 
enhance the quality and homogeneity of shell formation. For example, to cap a CdSe core 
with a CdS/ZnS shell, the Cd precursor is first injected followed by a subsequent 
injection of S precursor to create a CdS monolayer. This process is repeated multiple 
times until the desired number of CdS monolayers is achieved and then repeated with 
alternating Zn and S precursor injections, all while gradually increasing the temperature 
from ~120 to 260 
0
C. Once the desired nanocrystal size is achieved, the reaction is 
quickly cooled to arrest further growth. Upon successful synthesis and purification of the 
QDs, they can be transferred to water using various surface coating strategies.  
Quantum Dot Coating Strategies 
Because QDs are generally synthesized in non-polar organic solvents using 
hydrophobic coordinating ligands, they must be rendered water-soluble to be useful for 
biological applications. To do this, one of two methods has traditionally been employed. 
In the first process known as “ligand exchange,” coordinating ligands are displaced from 
the QD surface using small hydrophilic ligands that chelate the surface (Figure 2.3a). 
Thiolated ligands such as mercaptoacetic acid, mercaptopropionic acid or (3-
mercaptopropyl) trimethoxysilane are frequently used since thiols can bind to Zn or Cd 
atoms on the QD surface. Amine-containing ligands such as cysteamine can also be used. 
This method produces very small QDs but provides little colloidal stability, causing 
decreased fluorescence efficiency and aggregation in biological buffers [67, 68]. Due to 
the poor stability of the ligands and limitations in the number of different functional 
groups available for bioconjugation, it is difficult to conjugate antibodies and other 
ligands to the surface of these QDs.  
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In the second water solubilization procedure, the coordinating ligands of the QD 
are encapsulated by an amphiphilic polymer (Figure 2.3b) [16, 17, 22]. Several different 
types of amphiphilic polymers have been developed for coating quantum dots, including 
low molecular weight polymers [22, 69] , block copolymers [70], and triblock 
copolymers [17]. This method generates QDs of much greater brightness and stability, at 
the expense of producing large QDs in the range of 20-40 nm hydrodynamic diameter 
[13]. Several different functional groups, including carboxylic acids, amines, and thiols 
can be easily incorporated into the amphiphilic polymer for subsequent bioconjugation 
reactions. Consequently, amphiphilic polymer coating is the preferred coating strategy for 





























Figure 2.3. Common strategies for water solubilization of quantum dots. Quantum dots 
can be transferred to water using (a) ligand exchange or (b) amphiphilic polymer coating. 
Amphiphilic polymers interact with coordinating ligands on the QD surface through 




Quantum Dot Bioconjugation Strategies 
To enable specific binding to a target, biomolecules can be attached to the QD 
surface using either covalent or noncovalent methods. In covalent conjugation, functional 
groups incorporated on the surface coating of the QD are reacted with specific chemical 
moieties on the targeting biomolecule. For example, one common method of covalent 
conjugation is to utilize the chemical crosslinking agent 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide, known as EDC, to react carboxylic acids on the QD 
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surface with amine groups on peptides. Another method, often used to attach antibodies 
to QD surfaces, is to react malemide-activated quantum dots with reduced cysteines on 
the antibody [72].  
While covalent conjugation methods are generally preferred for cellular tracking 
studies, noncovalent conjugation methods can be advantageous in many applications. If 
the surface coating of a QD is highly charged, electrostatic interactions with an 
oppositely charged molecule can be exploited to assemble a QD bioaffinity probe. 
Electrostatic attraction is often used to assemble negatively charged DNA or siRNA 
molecules with positively charged QDs [73]. As later discussed in Chapter 3, proteins 
containing specialized peptide sequences such as a histidine tag [74] or an oligoaspartate 
tag [75] can directly chelate the surface of the QD noncovalently in a high affinity 
manner.  
Figure 2.4 illustrates some of the most typical bioconjugation strategies used in 
cellular studies. One extremely popular strategy is to use quantum dots covalently 
conjugated to streptavidin, a 60 kDa tetrameric protein that binds to the vitamin biotin 
with extremely high affinity (KD~10
-14 
M) [76]. This strategy is incredibly versatile, as a 
wide variety of biotinylated antibodies and proteins can be purchased from commercial 
vendors along with ready-made QD-streptavidin conjugates. Cell surface proteins can 
also be easily biotinylated using commercial kits and tracked using streptavidin-QDs. The 
greatest advantage of streptavidin-biotin conjugation is the ease of producing conjugates 
at near covalent affinity; nonetheless a few disadvantages do exist. Because biotin is a 
molecule native to cells, nonspecific binding of streptavidin-QDs to endogenous biotin 
can sometimes be problematic. Additionally, since each streptavidin contains four 
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binding sites for biotin, multivalent binding and crosslinking of biotinylated receptors can 









Since antibodies can be raised with high specificity for a wide variety of antigens, 
quantum dot-antibody conjugates have become one of the most commonly used QD 
probes in biological applications. Antibodies can be biotinylated and conjugated to QDs 
via streptavidin, or they can be directly conjugated to the QD surface. Nevertheless, 
antibodies also have several limitations. At 150 kDa, antibodies are large with 
hydrodynamic diameters exceeding 10 nm [77], adding considerable bulk to the QD 





 M), causing potential problems with crosslinking receptors and receptor 
dissociation during cellular tracking. Furthermore, since direct QD conjugation can 
sometimes alter the binding properties of the antibody, a two-layer strategy is often 
implemented for labeling targets, with a primary antibody used in addition to a QD-
secondary antibody conjugate. When this two-layer strategy is implemented, the total QD 
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complex can be extremely large, reaching up to 50 nm in hydrodynamic diameter [34]. 
As further discussed in Chapter 3, the large size of this QD complex can adversely affect 
receptor tracking in several different parts of the cell.  
Due to limitations with antibodies, an alternative strategy is to conjugate small 
ligands that bind to the desired target receptor with high specificity. These ligands 
include small molecules (e.g. RGD, folate), proteins and peptides. In particular, special 
cationic peptides, such as the HIV Tat peptide and the nuclear localization sequence 
(NLS) peptide, can serve as signaling sequences that help transport QDs to particular 
locations inside the cell [30, 31].   
2.4 Quantum Dots in Live Cell Imaging 
Indeed, several of these bioconjugation strategies have already been successfully 
implemented in live cell imaging studies. The vast majority of these studies have utilized 
QD probes to study the receptor dynamics and endocytosis of cell membrane proteins. In 
2003, Maxime Dahan and coworkers published the first paper utilizing QDs to track 
single receptors in live cells. Using commercial streptavidin-QDs coupled to biotinylated 
secondary antibody fragments along with a primary antibody, they were able to 
specifically detect glycine receptors on the surface of cultured spinal neurons. Because 
single quantum dots exhibit a hallmark “blinking” characteristic in which emitted 
fluorescence turns on and off intermittently [78], the authors could identify and track 
single receptors at high resolution. Glycine receptors could be seen alternating between 
free diffusion in the extrasynaptic space and confined diffusion in the synaptic domain. 
With QD technology, the movements of individual glycine receptors could be visualized 
in unprecedented detail, shedding insight into their fundamental dynamics [23].  
 20 
In 2004, Lidke et al. published the first paper utilizing QDs to visualize receptor 
signalizing transduction in live cells. They used streptavidin-QDs coupled to biotinylated 
epidermal growth factor (EGF) to image signal transduction of the classical cell surface 
EGF receptor, erbB1. They showed that binding of QD-EGF rapidly induced endocytosis 
of the EGF-QD-erbB1 complex via clathrin coated pits into endosomes. They were able 
to visualize internalized vesicles containing the EGF-QD-erbB1 complexes undergoing 
Brownian motion, vesicular fusion, and linear motion directed by microtubule motor 
proteins. Interestingly, the authors observed a novel process whereby EGF-QD-erbB1 
complexes uptaken by cell filopodia were transported in retrograde motion to cell body. 
This previously unreported mechanism was discovered due to the high resolution single-
molecule imaging made possible by QD technology [24]. The authors subsequently 
extended their study to investigating EGF receptor interactions by simultaneously using 
two colors of QDs to image EGF receptor dimerization [79].  
Since these two early studies, new breakthroughs in understanding membrane 
receptor dynamics continue to be made with QDs in practically every area of biology. 
QDs have been used to track numerous membrane receptors and membrane channels, 
including receptor tyrosine kinases [26, 27], G protein coupled receptors [25], integrins 
[28, 29], ion channels [80, 81], and aquaporins [82, 83]. In neurobiology, QDs have been 
used to study a wide variety of neuroreceptors in addition to glycine receptors, including 
AMPA [84, 85], GABA [86], NMDA [87], and acetylcholine receptors [88].  
QD tracking studies performed with intracellular receptors have been much more 
limited in scope and number. As explained in the next chapter, direct targeting of QDs to 
intracellular proteins in the cytosol remains a significant bottleneck to progress in 
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intracellular imaging. Nonetheless, a few advances have been made in this area. QDs 
have been successfully delivered into the cell cytoplasm using a variety of chemical and 
mechanical methods, including microinjection, electroporation, chemical transfection, 
and pinocytic loading [30, 89, 90]. In 2006, Courty and coworkers reported the first study 
incorporating QDs for intracellular protein tracking. In this study, the authors pre-
assembled streptavidin-QDs with biotinylated kinesin motor proteins and delivered the 
resulting conjugates into cells using pinocytic loading [89]. Inside cells, these QD-kinesin 
conjugates were shown to migrate processively on microtubules with a velocity and 
processivity similar to the motion of kinesins observed on purified microtubules in vitro. 
In a similar follow-up study performed with streptavidin-QDs and biotinylated myosin 
proteins, QD-myosin complexes could be seen processing on actin filaments in a hand-
over-hand manner [90].  
These studies demonstrate the breadth of versatility and the wealth of information 
that can be gained from single QD tracking. Nonetheless, they also reveal some 
significant challenges. Large multi-layer QD antibody conjugates have limited access to 
crowded locations such as neural synapses, which are typically only about 20 nm wide, 
and thus are unideal for imaging synaptic receptors [3, 91]. When using QDs to study 
receptor interactions, the large size of the QD labels may potentially hinder dimerization 
and other interactions. Furthermore, many challenges remain in the field of intracellular 
tracking. Delivery of freely diffusing QDs into the cytosol still remains difficult in many 
cases [92]. Importantly, QD probes that remain unbound to their target cannot be freely 
washed out from the cytosol. Consequently, direct quantum dot targeting of cytosolic 
proteins is difficult to achieve, and most studies have been performed by first assembling 
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QDs with a purified form of the protein of interest ex vivo prior to cytosolic delivery. 
These challenges have formed the incentive for the design of new and improved QD 
probes for the next generation of cellular tracking studies.  
2.5 Challenges and Opportunities 
Current-Generation Quantum Dots 
In spite of major successes with QDs in live cell imaging applications, traditional 
QDs have several disadvantages, and several opportunities exist for improving the design 
of QDs. The bioconjugation strategies depicted in Figure 2.4 represent idealized 
schematics—in reality, the bioconjugation process is difficult to control and yields highly 
variable results.  
Figure 2.5a shows a schematic of a standard commercial quantum dot with the 
traditional method of attaching protein targeting ligands to the surface. Slightly elongated 
in shape, commercial QDs are generally 15-35 nm in hydrodynamic diameter prior to 
modification with targeting ligands. During chemical conjugation, functional groups 
displayed on the polymer surface are reacted with random amines or thiols on the protein. 
Because the process is random, the resulting number of targeting ligands on the QD is 
random, resulting in a population of polydisperse, multivalent probes. The orientation of 
the ligands is likewise random, causing several of the protein active sites to be obstructed 
from binding their target. 
Large QDs exhibit increased binding steric hindrance and limited mobility 
compared to smaller probes. Due to their large surface area to volume ratio, large 
particles also display an increased propensity for nonspecific binding. The attachment of 
targeting ligands only serves to exacerbate the size of the existing QD, further reducing 
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its mobility in cellular environments. Large numbers of surface ligands can also increase 











Figure 2.5. Comparison of traditional commercial quantum dot probes and the next 
generation of improved quantum dot probes. (a) Traditional amphiphilic polymer-coated 
QDs conjugated to targeting ligands using stochastic chemical conjugation methods are 
large and multivalent. (b) Next-generation quantum dot probes should ideally be small 




Next-Generation Quantum Dots 
Several laboratories including our own are currently working towards reducing 
the size of QDs and improving their targeting strategies [51, 53, 93-96]. Figure 2.5b 
depicts a schematic of an ideal QD probe with improved binding characteristics. Ideally, 
these QD probes would have overall sizes comparable to globular proteins, which are 
generally 5 to 15 nm in hydrodynamic diameter. These QD probes would be monovalent 
with functional active sites directed outward. Not only would monovalent probes prevent 
unwanted receptor crosslinking and cell signaling, but limiting the number of targeting 
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ligands would also help to reduce the total size of the QD probe. The overarching goal in 
developing the next generation of QDs is to produce probes that are able to diffuse freely 
under a wide variety of cellular conditions, exhibiting reduced binding steric hindrance 
and enhanced resistance to nonspecific binding.  
2.6 Conclusions 
In recent years, quantum dots have garnered intense interest as biological imaging 
probes due to their intense and stable fluorescence. Since the first reports by Paul 
Alivisatos and Shuming Nie demonstrating utility of QDs in biological research in 1998, 
quantum dots have found widespread application in small animal imaging, disease 
biomarker detection, and cellular imaging [97, 98]. In the field of cellular imaging, the 
emergence of QD technology has allowed researchers to visualize receptor dynamics and 
protein interactions in an unprecedented detail previously not achievable with fluorescent 
dyes. Opportunities now exist for improving the design of QDs to enhance their 
applicability in a broader range of cellular conditions. This work will focus on reducing 
the overall size of QDs and their attached targeting ligands so that QDs can gain access to 
crowded locations such as neural synapses and the cellular cytosol. We will investigate 
new strategies for attaching targeting ligands to QDs with improved binding properties to 
their cellular proteins of interest. The results of our studies will help guide the design of 
next-generation nanoparticle-based imaging agents, paving the way for new scientific 








The size of nanoparticles has been shown to be an important parameter in many 
biological applications [99]. Nanoparticle size has been shown to have broad-ranging 
effects both on the cellular level, affecting cellular uptake [100, 101] and cellular toxicity 
[102], and on the whole-organism level, affecting nanoparticle biodistribution and 
clearance [77, 103, 104]. In several areas, small nanoparticles have been shown to exhibit 
several desirable advantages over their larger counterparts. For instance, in in vivo 
imaging applications, nanoparticles less than 6 nm have been shown to extravasate more 
uniformly into tumor tissue [104] and are cleared more rapidly from the body [77].  
The size of nanoparticles is likewise critical in live cell imaging. As discussed in 
Chapter 2, quantum dots have emerged as an incredibly promising tool for live cell 
imaging, especially single-molecule imaging. Nonetheless, the large size of conventional 
quantum dots has precluded their widespread use in imaging crowded cellular locations 
such as extracellular synapses, intracellular compartments, and organelles.  
In this chapter we summarize the effects of nanoparticle size on the cellular 
diffusion and nonspecific binding, focusing on the advantages of size-minimization. We 
discuss current research strategies to reduce the size of quantum dots and their targeting 
ligands. Finally, we present our own research strategy in choosing a size-minimized 
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quantum dot and tagging strategy for designing a novel optical imaging probe for cellular 
imaging.  
3.2 Size Effect on Quantum Dot Imaging of Various Cellular Compartments 
Size Effect on Intracellular Diffusion of Quantum Dots 
The cell cytoplasm is a crowded compartment comprised of a network of actin, 
myosin, and intermediate filaments densely packed with proteins and macromolecules 
[105, 106]. The classic drawing by David Goodsell shown in Figure 3.1 depicts a view of 
the crowded cellular interior, drawn to scale with all cytosolic components shown at 
physiologically accurate concentrations. The protein concentration in the cytoplasm of 
mammalian cells is extremely high, estimated to be 200-300 mg/ml, and can reach up to 
35% of the cell’s total weight [107]. At this concentration, transport of macromolecules 
in cellular interiors is significantly affected by intermolecular interactions. Consequently, 
physical properties such as size, geometry, and surface chemistry all play important roles 




















Figure 3.1. An illustration depicting the crowded cytoplasm of yeast, S. cerevisiae. All 





Several previous studies have characterized the role of size on the diffusion of 
macromolecules within the cytoplasm [109-112]. For example, Verkman and coworkers 
measured the effect of molecular weight on the diffusion of FITC-labeled 
polysaccharides in cytoplasm using fluorescence recovery after photobleaching (FRAP). 
As shown in Figure 3.2, dextrans smaller than 500 kDa were found to diffuse freely 
inside the cytoplasm at approximately a 4.5-fold slower rate than their diffusion in water. 
Dextrans larger than 1000 kDa (~15 nm hydrodynamic diameter) started to exhibit 
impaired mobility, while 2000 kDa dextrans (~30 nm hydrodynamic diameter) were 












Figure 3.2. Effect of molecular size on the diffusion of FITC-labeled dextrans in 
cytoplasm as compared to their diffusion in water. The ratio of the dextran’s diffusion 
coefficient in cytoplasm (Dcyto) to its diffusion coefficient in water (Dwater) is plotted as a 




Our laboratory has studied the effect of size on the cytoplasmic diffusion of 
quantum dots and found the results to be consistent with the data obtained for diffusion of 
dextrans. In this study, multidentate polymer coated quantum dots of three different sizes 
were loaded into the cytoplasm of A431 cells using a technique called pinocytic loading 
[113]. As shown in Figure 3.3, large QDs with 40 nm and 28 nm hydrodynamic 
diameters both exhibited strongly limited mobility in the cell interior. Only the 10 nm 
















Figure 3.3. Effect of nanoparticle size on the diffusion of QDs in cytoplasm. 
Representative trajectories are shown for QDs of three different sizes, 10 nm, 28 nm, and 
40 nm that have been loaded into the cytoplasm of A431 cells using pinocytic loading. 




In summary, studies have shown that small particles are able to diffuse freely in 
cytoplasm, while the diffusion of large particles can be greatly impaired. For both QDs 
and dextrans, the size cutoff for free diffusion has been observed to be about 15-20 nm, 
although this size cutoff may naturally vary for different macromolecules with different 
surface properties. 
Size Effect on Cellular Surface Diffusion of Quantum Dots 
While nanoparticle size has a great effect on diffusion in confined environments 
such as the cell interior, it has little effect on diffusion in unconfined regions of the cell 
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surface. In general, tracking of cell surface receptors is not affected by the size of nano-
sized probes. Because the viscosity of the cell membrane is 100- to 1000-fold greater 
than the viscosity of the extracellular medium, nanoparticles exhibit very little drag force 
on the surrounding medium. Consequently, the viscosity of the cellular membrane is the 
limiting factor governing cell surface receptor diffusion in unconfined environments. 
 In contrast, the size and valence of nanoparticle probes do exhibit significant 
effects on receptor movement in confined regions of the cell surface such as neural 
synapses [84]. The width of the synaptic cleft is only an average of ~20 nm [91]. As a 
result, commercial QDs, which typically range from 15 to 35 nm in hydrodynamic 
diameter, often exhibit difficulty accessing the synaptic cleft. In 2007, Groc et al. 
compared the labeling of glutamate receptors in the synaptic clefts of hippocampal 
neurons using commercial QD-antibody, dye-antibody, and dye-ligand complexes. They 
discovered that the smaller probes were able to penetrate the synaptic clefts more easily, 
with the number of dye-ligand complexes inside the synaptic cleft found to be four times 
greater than the number of QD-antibody complexes. They further discovered that the 
small dye-ligand probes were able to detect populations of fast diffusing synaptic 
receptors better than the larger QD-antibody probes [84]. In conclusion, the results of this 
study suggest that the development of smaller probes could allow researchers to obtain 
more accurate information about receptor movements in confined environments.  
Size Effect on Quantum Dot Transport into Cell Nucleus 
Interestingly, several groups have observed an effect of nanoparticle size on the 
translocation of QDs from the cytoplasm into the nucleus [32, 114-116]. In a study 
reported in 2005, Lovric and coworkers prepared green cysteamine-coated CdTe QDs 
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with 2.2 nm hydrodynamic diameter and red cysteamine-coated CdTe QDs with 5.5 
hydrodynamic diameter. When these QDs were passively loaded into murine microglial 
cells, the green QDs were found to spontaneously translocate into the nuclei of cells 
while the red QDs remained only in the cytoplasm. The authors found that entry of the 
green QDs into the nuclei could be abolished if the green QDs were coated with albumin, 
suggesting that an increase in overall nanoparticle size could block entry into the nucleus 
[114]. Nabiev et al. later confirmed this size effect in a similar study with human 
macrophages, reporting a size-cutoff of approximately 3 nm for QD entry into the 
nucleus. The researchers further determined that the mechanism for nuclear transport of 
small QDs occurs via active transport on microtubules, and not passive diffusion [32].  
 The nuclear pore typically allows passage of macromolecules up to 9 nm in 
diameter [117]. Therefore, it is interesting that the apparent size-cutoff for nanoparticle 
entry appears to be much smaller. Since nanoparticles coated with small ligand coatings 
like cysteamine exhibit poor colloidal stability in biological buffers, it is possible that 
particle aggregation may account for an increase in size. It is also possible that absorption 
of proteins onto the nanoparticle surface may increase the effective size of the red QDs, 
precluding their entry into nuclear pores. As discussed in the next section, the size of a 
nanoparticle can influence its propensity to nonspecifically adsorb to proteins.  
3.3 Size Effect on Nonspecific Binding of Quantum Dots 
 In addition to enhancing nanoparticle access to confined regions of the cell, 
another compelling reason for moving towards size-minimized nanoparticles is that small 
colloids are inherently more resistant to nonspecific binding than larger ones. Smaller 
colloids diffuse faster than larger colloids as shown by the Stokes-Einstein equation,  
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     Equation 3.1  
 
where r is the radius of the colloid, η is the viscosity of the solvent, T is the temperature, 
and k equals the Boltzmann’s constant. The high diffusivity of small colloids renders 
them less capable of forming bonds with other molecules while concomitantly helping to 
disrupt weak intermolecular interactions. As a result, small colloids are less likely to form 
nonspecific interactions than larger colloids.  
The high degree of surface curvature inherent to small colloids also helps to 
prevent nonspecific binding. As shown in Figure 3.4, large colloids have a flatter surface, 
thereby increasing the effective surface area capable of forming multivalent interactions. 
On the other hand, small colloids are less capable of forming multivalent interactions 











Figure 3.4. Effect of nanoparticle surface curvature on multivalent binding interactions. 
Small nanoparticles have a higher degree of surface curvature and are less likely to form 
multivalent interactions than larger nanoparticles.  
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Previous work done in our laboratory has provided evidence to support the theory 
that small nanoparticles are inherently resistant to nonspecific binding. In particular, 
small quantum dots less than ~6 nm in hydrodynamic diameter were observed to exhibit a 
dramatically enhanced resistance towards nonspecific binding to serum proteins 
compared to larger quantum dots. In this study, CdTe QDs with 3 nm cores and 5 nm 
cores were fully coated with thioglycerol to achieve particles with final hydrodynamic 
diameters of 4 nm and 6 nm respectively. The thioglycerol coated QDs were incubated in 
either phosphate buffered saline (PBS), 50% fetal bovine serum (FBS), or 3% bovine 
serum albumin (BSA) at 37
0
C for 1 hour. Samples were subsequently resolved in a 0.7% 
agarose gel and visualized under ultraviolet illumination. As shown in Figure 3.5, 6 nm 
QDs exhibited great changes in electrophoretic mobility when incubated in serum and 
albumin, indicating that nonspecific binding between QDs and serum proteins has 
occurred. In contrast, 4 nm QDs exhibited little change in electrophoretic mobility when 























Figure 3.5. Nonspecific binding of quantum dots of different sizes to serum and albumin. 
QDs with 4 nm and 6 nm hydrodynamic diameters were incubated in PBS (left lane), 
50% FBS (middle lane), or 3% BSA (right lane) at 37
0
C for 1 hour and resolved using 




We also observed the same property of resistance towards nonspecific binding for 
other types of small nanoparticles. In a study performed with gold nanoparticles, three 
sizes of gold nanoparticles (Ted Pella)—2 nm, 5 nm, and 10 nm—were fully coated with 
methoxy-PEG-thiol (356.48 Da, Quanta Biodesign) to achieve particles with final 
hydrodynamic diameters of 5 nm, 9 nm, and 13 nm respectively. Pegylated gold 
nanoparticles were incubated in either PBS or 50% FBS at 37
0
C for 1 hour. Samples were 
subsequently resolved on a 1% agarose gel and visualized using silver enhancement (LI 
Silver Enhancement Kit, Nanoprobes). Out of the three different sizes of gold shown in 
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Figure 3.6, only the smallest gold nanoparticles with a final hydrodynamic diameter of 5 












Figure 3.6. Nonspecific binding of gold nanoparticles of different sizes to fetal bovine 
serum. Three sizes of gold nanoparticles with final hydrodynamic diameters of 5, 9, and 
13 nm were incubated in either PBS or 50% fetal bovine serum at 37
0
C for 1 hour and 




Due to the advantages of size-minimized nanoparticles in reducing nonspecific 
binding and enhancing cellular diffusion, the development of new strategies to minimize 
the size of QD probes has become an active area of research. Although ultra-small QDs 
(<6 nm diameter) have already been incorporated in some of the studies mentioned 
above, virtually all of these studies have implemented uncapped CdTe QDs containing 
small ligand coatings such as cysteamine and thioglycerol. “Core-only” QDs such as 
CdTe are typically smaller than their core-shell counterparts but exhibit much lower 
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photostability. Small-ligand coatings easily desorb from the QD surface in complex 
biological fluids, offering little colloidal stability to the underlying QD [67, 68]. Thus, an 
express need remains for engineering new types of small QDs with high photostability 
and colloidal stability. So far, many of the advances in producing size-minimized QDs 
have been driven by an effort to improve the stability of thin coatings. These efforts are 
summarized in the next section.  
3.4 Size-Minimized Quantum Dots 
As discussed in Chapter 2, QDs are often synthesized in organic solvents using 
hydrophobic coordinating ligands to control their growth rate. As a result, QDs must be 
phase transferred to water prior to use with biological systems. The most common 
method of water solubilization is to encapsulate the QD’s coordinating ligands with an 
amphiphilic polymer (Figure 3.7a). This strategy is used to coat the majority of 
commercially available QDs, including the widely popular Invitrogen Qdots. Coating 
with amphiphilic polymer generates QDs with excellent brightness and stability at the 
expense of producing large QDs in the range of 20-40 nm hydrodynamic diameter [13, 
15].  
Since decreased stability and increased nonspecific interactions often accompany 
a reduction in the thickness of the surface coating, reducing QD size remains a 
considerable challenge. Early generations of QDs with thin coatings often incorporated 
small monodentate ligands such as mercaptoacetic acid and mercaptopropionic acid that 
could chelate atoms on the QD surface. These hydrophilic ligands were used to displace 
the hydrophobic coordinating ligands from the QD surface to produce extremely compact 
QDs. Unfortunately, due to the weak interaction of monodentate ligands with QD surface 
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atoms, desorption of these ligands from the QD surface could occur in less than 24 hours 





















Figure 3.7. Traditional versus new compact QD coatings. (a) Schematic diagram of a 
traditional amphiphilic polymer coated QD. Novel compact coatings include (b) bidentate 
ligands such as dihydrolipoic acid-PEG ligands developed by Mattoussi and Bawendi, 




As such, recent advances have focused on increasing the binding affinity of these 
hydrophilic ligands to the QD surface through multidentate interactions. The Mattoussi 
and Bawendi groups have developed a bidentate ligand coating based on dihydrolipoic 
acid grafted to a short linear PEG chain. This DHLA-PEG coating (Figure 3.7b) is 
anchored to the QD via coordination of dithiols in a brush-like monolayer [53, 55]. 
Quantum dots coated with DHLA-PEG have already been successfully implemented in 
several live-cell imaging studies [10, 53]. Nonetheless, oxidation and dimerization of the 
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thiol groups can cause the bidentate ligands to become unstable over time, and the effects 
of this instability have been reported in as little as 1 week [54].  
We have observed that the long-term colloidal stability and photostability of the 
QD can be enhanced by further increasing the number of binding motifs in the polymer 
coating. Our laboratory has developed a multidentate  polymer coating based on a 
polyacrylic acid backbone modified with thiols and amines that chelate the QD surface in 
a flat-wrapping conformation [50, 51] (Figure 3.7c). Because this conformation is very 
stable thermodynamically, these multidentate polymer coated QDs exhibit excellent 
optical properties and maintain their stability for several months, even years. Similarly, 
the Bawendi group has developed a polymer coating that binds to the QD surface through 
multiple imidazole groups in a multidentate fashion [54]. The development of these new 
multidentate surface coatings enables QD size reduction without compromising QD 
stability—a remarkable achievement that will prove to be beneficial in many biological 
imaging applications.  
 
3.5 Size-Minimized Tagging Strategies 
The size of the QD is of paramount importance in reducing steric hindrance and 
ensuring adequate diffusivity in cellular compartments. Equally as crucial is the “tagging 
strategy”, the method by which the QD recognizes or is attached to its target biomolecule 
of interest. Ideally, QD-probes should bind their targets with high affinity and be 
monovalent to avoid crosslinking receptors. Size and tagging are intricately related, as 
monovalent probes would be smaller and able to diffuse faster than their multivalent 
counterparts.  
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As shown in Figure 3.8a, the most popular conventional approach to QD targeting 
involves the use of antibodies. At 150 kDa, the antibodies used to target QDs to cell 




M) [35]. Due to the large QD surface area available for coupling, multiple antibodies are 
usually bound to the surface, resulting in a total construct that can reach up to 50 nm in 







Figure 3.8. Traditional versus new tagging strategies. (a) A popular traditional tagging 
strategy involves coupling of biotinylated antibodies to commercially available 
streptavidin-coated QDs. New size-minimized tagging strategies include: (b) His-tag 
chelation, (c) Monovalent streptavidin – biotin binding, and (d) HaloTagging. See text for 






Recently, the emergence of new site-specific tagging strategies has eliminated the 
need for antibodies altogether. These techniques include a variety of affinity chelation, 
enzyme-mediated, and covalent labeling techniques. Figure 3.8 b – d highlights some of 
the most promising tagging strategies for quantum dots.  
One such approach utilizes the polyhistidine tags (“his-tags”) commonly 
introduced into recombinant protein sequences for Ni
2+ 





. His-tagged proteins can self-assemble onto a QD 
surface at well-defined orientations if the QD surface coating is adequately porous, a 
requirement met by most new compact multidentate coatings [53, 74, 121] (Figure 3.8b). 





M) [122], and further studies are needed to see if the his-tag-QD interaction can 
withstand complex biological environments for long periods of time without dissociation. 
Nonetheless, the Mattoussi group has shown that DHLA-PEG QDs conjugated to his-
tagged peptides are able to retain their integrity in intracellular endosomes up to 72 hours 
[123, 124]. As an alternative to direct his-tag chelation of the QD surface, Roullier and 
coworkers used QDs displaying a surface trisNTA moiety to enhance the his-tag binding 
affinity. By expressing type I interferon receptors fused to a decahistidine tag on the 
surfaces of cells, the authors could track these receptors on a single-molecule level using 
QD-trisNTA conjugates [93].  
Using a combination of the his-tag and biotin-streptavidin binding techniques, the 
Ting group has developed an elegant method for achieving monovalent binding (Figure 
3.8c). This technique successfully exploits the strength of streptavidin-biotin binding (KD 
~10
-15 
M) while circumventing the multivalency problems associated with native 
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streptavidin, which contains four biotin-binding sites. First, the authors engineered a 
monovalent version of streptavidin that can be chelated to DHLA-PEG-QDs using a his-
tag. Next, they recombinantly fused their cellular surface protein of interest to a small 
acceptor peptide that can be biotinylated upon the addition of a biotin ligase known as 
“BirA.” Upon adding BirA, ATP, and biotin to the cellular medium, specific staining 
could be achieved with monovalent streptavidin-QDs at high affinity. Due to the compact 
size of the monovalent streptavidin-QDs, Howarth and coworkers were able to 
successfully track glutamate receptors in crowded neuronal synapses [10]. 
While Ting’s “monovalent streptavidin” technique requires the addition of a 
separate enzyme to produce labeling, other techniques directly incorporate an enzymatic 
tag for labeling. As shown in Figure 3.8d, the “HaloTagging” technique employs a 33 
kDa haloalkane dehalogenase (“HaloTag protein”) that has been mutated to form a 
covalent bond with a 6-carbon chloroalkane group (“HaloTag ligand”). When the 
HaloTag protein is genetically fused to the cellular protein of interest, it can readily react 
with QDs displaying surface HaloTag ligands. We have isolated this technique as a 
promising candidate for single-molecule imaging studies due to several notable 
advantages. In addition to the covalent nature of the binding and the small size of the 







). Most importantly, HaloTagging is compatible with intracellular 
labeling, whereas most current techniques are limited only to cell surface labeling [40, 
125].  
A few other enzymatic labeling techniques have also been applied to QDs. The 
“SNAP-Tagging” technique involves a 20 kDa human DNA repair protein that has been 
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mutated to form a covalent bond with O
6
-benzylguanine (BG) groups. In the same 
manner that HaloTag fusion proteins bind covalently to chloroalkane groups, SNAP-Tag 
proteins can bind covalently to benzylguanine groups, both on the cell surface and 
intracellularly [126]. One preliminary study has shown that QDs displaying surface BG 
groups can bind to purified SNAP-Tag proteins in solution, although this technique has 
not yet been extended successfully to labeling of cellular proteins [127]. Bonasio and 
coworkers have developed another strategy involving cutinase, a 22 kDa fungal serine 
esterase that forms covalent adducts with p-nitrophenyl phosphonate presenting alkyl 
chains. In a proof-of-concept study, Bonasio et al. demonstrated that QDs displaying p-
nitrophenyl phosphonate groups could bind to cells expressing cell surface proteins 
grafted with cutinase [128].   
Several other site-specific labeling techniques have been demonstrated with 
fluorescent dyes, some which may potentially be adopted with QDs [36-39]. These 
include, but are not limited to affinity methods such as the tetracysteine [129] and oligo-
aspartate tags [75], and enzymatic methods such as the CLIP-Tag [130]  and acyl carrier 
protein methods [131]. Table 3.1 summarizes several of the major site-specific labeling 
techniques described in the literature. Research in new tagging strategies is vital for 
generating orthogonal labeling techniques that can be used for multi-color QD tracking 
experiments. Indeed, the possibilities are endless, and new tagging strategies continue to 




Table 3.1. Site-specific tagging strategies for targeting fluorophores to cellular proteins. 





3.6 Size-Minimized Quantum Dot and Tagging Strategy Selection 
Our goal is to engineer a quantum-dot targeting ligand complex that provides 
enough versatility to accommodate as many different types of single-molecule tracking 
studies as possible. Ideally, this means that the QD-ligand complex should be compatible 
with both intracellular and cell surface environments. This would require QDs to be as 
small as possible while still providing the photostability needed to sustain prolonged UV 
illumination for long-term tracking. Core-shell QDs composed of materials as CdSe(ZnS) 
and CdSe(CdS/ZnS) lend far greater photostability than “core-only” QDs such as CdTe, 
although the latter are slightly smaller in size [47]. Hence, we have chosen to use 
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CdSe(CdS/CdZnS/ZnS) QDs, taking advantage of novel surface coatings to reduce QD 
size.  
As a surface coating, we have chosen to use the multidentate polymer coating 
(Figure 1c) previously engineered in our laboratory [50, 51]. Multidentate-coatings QDs 
offer greater stability than bidentate coatings (Figure 1b), and a flat-wrapping 
conformation results in a smaller size than the extended-brush conformation of bidentate 
ligands. Moreover, the multidentate polyacrylic acid-based polymer contains several 
convenient functional groups, including carboxylic acids, thiols, and amines, readily 
available for bioconjugation.  
After carefully considering the plethora of site-specific tagging strategies that 
have been used previously with fluorescent dyes, we chose the HaloTag tagging strategy 
based on the following four criteria: (1) labeling kinetics/speed of reaction, (2) quantum 
dot compatibility, (3) intracellular compatibility, (4) tag size, and (5) feasibility of use. 
Thus far, very few existing techniques are compatible with intracellular imaging. Of the 
site-specific labeling strategies listed in Table 3.1, only three techniques—tetracysteine, 
SNAP-Tag, and HaloTag labeling—are compatible with intracellular labeling. Of these 
three techniques, the compatibility of tetracysteine tagging with QD use remains 
questionable. While the tetracysteine tag may potentially chelate the surface of QDs 
containing cadmium and zinc, it is unclear whether the binding affinity will be strong 
enough to withstand harsh biological environments.  
Both the SNAP-Tag and HaloTag labeling strategies result in covalent binding to 
their targets. Although the SNAP-Tag (~20 kDa) is slightly smaller in size than the 
HaloTag (33 kDa), it exhibits much slower labeling kinetics than the HaloTag. The 
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second-order rate constant for HaloTag protein binding to TMR ligand, a HaloTag 






, only slightly lower 







As a result, the HaloTag binding reaction reaches completion in less than 5 minutes at 25 
0
C [40]. In contrast, the second-order rate constant for SNAP-Tag binding to 




 [126].  
Another particularly attractive advantage is that the HaloTag technology is further 
developed and more thoroughly characterized than many of the other tagging strategies. 
Several HaloTag vectors and fluorescent ligands are already commercially available 
through Promega Corporation (Madison, Wisconsin). The binding specificity of the 
HaloTag ligand to both intracellular and cell surface HaloTag protein has also been 
thoroughly demonstrated. For example, Los and coworkers showed that the TMR ligand 
could specifically bind to an intracellular p65-HaloTag fusion protein inside the 
cytoplasm of living cells. In this experiment, HeLa cells were transfected with the p65-
HaloTag protein and stained with TMR ligand. The cell lysate was subsequently 
collected and resolved using an SDS-PAGE gel. A fluorescent band corresponding to the 
TMR ligand-labeled p65-HaloTag protein was found only in transfected cells; 
nontransfected cells stained with TMR ligand exhibited no fluorescent protein bands. 
These results indicate that the HaloTag ligand can indeed recognize target HaloTag 
protein with high specificity in complex intracellular environments [40]. In another 
experiment, Svendsen and coworkers showed that HEK293 cells expressing a surface 
HaloTag protein could be labeled with biotinylated HaloTag ligand and captured onto 
streptavidin coated plates. Native HEK293 cells labeled with biotinylated HaloTag ligand 
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remained uncaptured, thereby demonstrating specific binding of the HaloTag ligand to 
cell surface HaloTag proteins [137]. Altogether, the high specificity of HaloTag binding 
has permitted its successful application in a wide range of cellular and in vivo imaging 
studies [138-142]. Based on these initial qualities, the HaloTag strategy appears to be a 
promising tagging strategy for designing size-minimized QD probes for cellular imaging. 
3.7 Conclusions 
In recent years new strategies for reducing the size of quantum dots have emerged 
along with improved tagging strategies for site-specifically labeling target proteins. These 
strategies have the potential to greatly advance the field of quantum dot imaging by 
improving QD access to many regions of the cell. In particular, the HaloTag strategy is 
especially noteworthy due to its covalent nature, fast labeling kinetics, and ability to be 
used intracellularly. Early reports have indicated that HaloTag ligands can indeed be 
coupled to commercial QDs, and that the resulting conjugates do retain their ability to 
bind HaloTag protein [125, 143]. The next step is to investigate whether this technology 
can be translated into a size-minimized technology. In the remaining chapters, we will 
investigate whether size-minimized HaloTag ligands can be coupled to size-minimized 
multidentate polymer coated QDs. It will be critical to determine if QD-HTL conjugates 
can bind to their target proteins at the low staining concentrations required for single-
molecule imaging. It will also be fundamentally important to determine whether QD-
HTLs can be prepared at the monovalency required to prevent receptor crosslinking.  
This work is significant because it will present a systematic study of the 
parameters needed to optimize HaloTagging as a direct QD labeling procedure. It is the 
first study that seeks to optimize an entirely covalent strategy for site-specifically labeling 
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and tracking cellular proteins using small QDs. It is the first study that seeks to apply 
size-minimized quantum dot-HaloTag ligand conjugates for single-molecule imaging in 
live cells. Finally, this work is significant due to its potential for intracellular labeling. 
This work will shed new insight on the interaction between QDs and covalent size-
minimized tagging strategies, establishing a foundation of knowledge for developing new 
technologies that transform our ability to visualize cellular and molecular interactions.  
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CHAPTER 4 
SYNTHESIS AND CHARACTERIZATION OF SIZE-MINIMIZED 
QUANTUM DOT-HALOTAG LIGAND CONJUGATES 
 
4.1 Introduction 
The goal of our study is to engineer a quantum dot targeting ligand complex that 
provides enough versatility to perform single-molecule imaging under a wide variety of 
cellular conditions. As discussed in Chapter 3, we have isolated the HaloTag tagging 
strategy as having exceptional promise for single-molecule QD imaging due to its 
covalent nature and potential for intracellular labeling. We have further decided to use 
this tagging strategy in conjunction with in size-minimized multidentate polymer coated 
QDs, which have been shown to exhibit high colloidal stability in complex biological 
environments compared to other types of small QDs. The rationale is that small QD-
targeting ligand constructs are necessary to diffuse in cell interiors, and that a covalent 
strategy is ideal for preventing dissociation of the QD from the protein of interest during 
imaging.   
 In this chapter, we seek to identify the reaction conditions needed to react the 
HaloTag ligand with compact multidentate polymer coated QDs. We seek to optimize the 
quantum dot surface chemistry needed to achieve specific binding between QD-HTL 
conjugates and their target HaloTag proteins. As a preface to investigating the 
performance of our QD-HTL conjugates in more complex cellular environments, we will 
assess their binding to purified HaloTag protein in simple aqueous solutions.  
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Although our primary focus is to use QD-HTLs for direct targeting of specific 
proteins in the cellular context, purified QD-HaloTag fusion protein conjugates have a 
wide variety of uses. QD-HaloTag fusions with fluorescence proteins or luciferases can 
be used as fluorescence or bioluminescence resonance energy transfer (FRET or BRET) 
sensors [143]. As an alternative to direct targeting of cellular HTP, QDs can first be 
assembled with HaloTagged proteins of interest in vitro prior to delivery into living cells 
or whole organisms. In all of these methods, the HaloTag strategy offers the advantage of 
providing covalent conjugation at a controlled orientation and stoichiometry. Thus, a 
systematic characterization of QD-HTL binding to purified HaloTag protein, as presented 
in this chapter, will be beneficial not only for cellular labeling, but for all of these 
applications. 
4.2 Materials and Methods 
Multidentate Polymer Coated Quantum Dots 
CdSe(CdS/CdZnS/ZnS) QDs were synthesized according to the following 
procedure. Briefly CdSe QD “cores” of roughly 3.43 nm were synthesized as previously 
described [144] and then purified from unreacted precursors via extraction with hexane 
and methanol three times [145]. The QDs in the hexane layer were collected into a 50 ml 
centrifuge tube and precipitated using an excess of acetone. Following centrifugation at 
5000 g for 15 min, insoluble QDs were resuspended in a mixture of octadecene and oleic 
acid. The CdSe QDs were then capped with two monolayers of CdS, one monolayer of 
CdZnS, and one and a half monolayers of ZnS while gradually increasing the temperature 
from 160 to 220 
0
C [63, 64, 66]. The resulting QD mixture was cooled to room 
temperature and purified with six rounds of hexane-methanol extraction. Again, the QDs 
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were precipitated using acetone and pelleted by centrifugation at 5000 g for 15 min. 
Finally, the purified QDs were resuspended in chloroform, where they could be stored 
long term at -20 
0
C. The theoretical QD size was calculated from its known correlation 
with the first exciton peak [145-147], and also verified empirically using TEM. 
CdSe(CdS/CdZnS/ZnS) QDs were subsequently coated with multidentate polymer as 
detailed extensively by Nie et al [51].  
HaloTag Ligands 
Nitrophenol carbonate terminated HaloTag ligands of two sizes, 700 MW (697.16 
g/mol) and 2500 MW (~2503 g/mol) were generously synthesized by Promega 
Corporation. 500 MW (508.99 g/mol) succinimidyl ester O4 ligand was purchased from 
Promega Corporation. The structure of these ligands is displayed in Figure 4.2. HaloTag 
ligands were typically dissolved to 100 mM stock concentrations in anhydrous DMSO, 




1000 MW PEG (1074.20 g/mol, amino-dPEG24-alcohol) and 370 MW PEG 
(369.45 g/mol, amino-dPEG8-alcohol) were obtained from Quanta Biodesign. 2000 MW 
PEG (CH3O-PEG-NH2) was obtained from Rapp Polymere. 1000 MW Fluorescein-PEG- 
amine (FITC-PEG-NH2) was obtained from Nanocs.  
Determination of Nitrophenol Carbonate HaloTag Ligand-Quantum Dot Reaction 
Kinetics 
The nitrophenol carbonate group of the 700 and 2500 MW HTLs react with 
primary amines of the QD multidentate polymer coating under basic pH (pH 8-10) to 
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produce a covalent urethane linkage [148] (Figure 4.1). For determination of the reaction 
kinetics between nitrophenol carbonate HTLs and multidentate polymer coated QDs, a 
10-fold molar excess of HTLs was incubated with QDs in 10 mM borate buffer (pH 8.5) 
at 27 
0
C. Simultaneously, an identical sample was prepared containing only HTL at the 
identical concentration. Nitrophenol absorbance at 400 nm was monitored at several time 
points over the course of a 24 hour period. To obtain the final reaction kinetic curve, 
absorbance of the “ligand only” sample was subtracted from the QD-ligand reaction 
sample to account for hydrolysis of the ligand over time. This procedure was performed 
for both 700 MW and 2500 MW ligands.  
Quantum Dot Surface Functionalization with Nitrophenol Carbonate HaloTag 
Ligands 
Nitrophenol carbonate HaloTag ligands were added dropwise to QDs and allowed 
to react in 10 mM borate buffer (pH 8.5) while stirring for at least 20 hours at 27 
0
C. 
Nitrophenol by-product and unreacted ligand were then either removed with 
ultrafiltration or dialysis, as described below. For non-pegylated QD-HTLs, the final QD-
HTLs were collected into PBS buffer (pH 7.4). If subsequent PEG modification was 
desired, QD-HTLs were collected into 25 mM MES buffer (pH 6). Final conjugates were 
centrifuged at 7000 g for 10 minutes to remove aggregates.  
Quantum Dot Surface Functionalization with Succinimidyl Ester HaloTag Ligands 
Succinimidyl ester HaloTag ligands were added dropwise to QDs and allowed to 
react in 10 mM borate buffer (pH 8.5) while stirring for at least 20 hours at 27 
0
C. 
Succinimide by-product and unreacted ligand were then either removed with 
 52 
ultrafiltration or dialysis, as described below. Final QD-HTLs were collected into PBS 
buffer (pH 7.4).  
Pegylation of Quantum Dot-HaloTag Ligand Conjugates 
Linear PEG polymers containing terminal amine groups were reacted to 
carboxylic acids on the multidentate polymer coated QDs using standard carbodiimide 
chemistry. Briefly, a solution of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) 
crosslinking reagent (Sigma Aldrich) was added dropwise to a well-stirred solution of 
QD-HTLs and amine-terminated PEGs in 25 mM MES (pH 6) and allowed to react 
overnight at 27 
0
C. 
 To optimize the pegylation procedure, parameters affecting the stability of the 
PEG-QD conjugates were investigated. QD samples containing various amounts of PEG 
(from 5 to 200,000 molar excess) and EDC (from 1,000 to 100,000 molar excess) were 
monitored over the course of a week. Samples were examined using three methods: (1) 
visually, for examination of pellet; (2) by spectrofluorometry to detect loss of 
fluorescence intensity; and (3) by gel electrophoresis to detect aggregation. Additionally, 
gel electrophoresis was used to determine the amount of PEG needed to completely coat 
the QD surface.  
Purification of Quantum Dot-HaloTag Ligand Conjugates  
Two different methods of purifying QD-HTL conjugates were investigated: (1) 
purification using ultrafiltration columns and (2) dialysis. In the first method, ~200 µl of 
QD-HTL was loaded into a Nanosep 10K centrifugal device (Pall Lifesciences) and 
centrifuged at 6000 rpm for 5 min. The retentate was resuspended back to 200 µl in PBS, 
and the centrifugation was repeated. Samples were typically purified with 2-4 rounds of 
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centrifugation at 6000 rpm for 5 min each, depending on the amount of excess HTL used 
during reaction. If subsequent pegylation was required, QD-HTL samples were collected 
into MES buffer during the final round of centrifugation.  
 In the second method, QD-HTL samples were dialyzed in PBS using 20K 
molecular weight cutoff (MWCO) Slide-a-lyzer MINI dialysis devices (Thermo 
Scientific Pierce) with at least 5 buffer changes over the course of 3 hours, then allowed 
to dialyze overnight with one final buffer change. If subsequent pegylation was required, 
QD-HTL samples were exchanged into MES buffer during the final few rounds of 
dialysis.  
For pegylated QD-HTLs, the number and placement of the purification steps was 
also investigated. QD-HTLs were either purified (1) before pegylation, (2) after 
pegylation, or (3) both prior to and after pegylation.  
Estimation of the Number of PEGs on the Quantum Dot Surface 
The number of PEG molecules on the surface of the QD was estimated using 
fluorescein terminated PEG. QDs were reacted with 10,000 molar excess of fluorescein-
1K PEG-amine (Nanocs, Inc) using 7,500 molar excess of EDC. The resulting conjugates 
were loaded into 20K MWCO dialysis units and dialyzed extensively into PBS for 4 
days. A control sample containing only QDs and 10,000 excess fluorescein-1K PEG was 
simultaneously purified to ensure complete removal of fluorescein-1K PEG. Upon 
purification, the number of PEGs on the QD surface was estimated using the extinction 








Estimation of the Number of HaloTag Ligands on the Quantum Dot Surface 
The number of ligands on the QD surface was estimated by comparing the 
number of free primary amines on the QD before and after conjugation with HTL, as 
measured using a fluorescamine assay. A series of glycine standards ranging from 500 
nM to 20 µM was prepared in 50 mM borate buffer (pH 8.5), and a 5 mg/ml solution of 
fluorescamine was freshly prepared in DMSO. The assay was initiated by mixing equal 
parts of fluorescamine solution with glycine standard. After 30 minutes of reaction in the 
dark, the fluorescence intensity was measured at 470 nm using 380 nm excitation. In the 
same manner, a series of QD-HTLs containing various amounts of ligand on the surface 
were prepared in 50 mM borate buffer and assayed at a final concentration of 600 nM.  
QD-HTL Hydrodynamic Size Analysis  
The hydrodynamic size of the QD-HTLs was determined by dynamic light 
scattering (DLS) using a Brookhaven Instruments 90Plus Particle Size Analyzer. In 
general, 300 µl of at least 750 nM of QD-HTL was required in order to achieve an ideal 
count rate of 1 million counts per second and a sample quality ranging from 9-10 (with 
10 being the highest quality). To ensure complete removal of by-products and unreacted 
reagents, which can interfere with size measurement, samples were dialyzed in PBS using 
20K MWCO Slide-a-lyzer MINI dialysis devices (Thermo Scientific Pierce) with 8 
buffer changes for 22 hours before DLS measurement. Samples were sonicated for 15 
min immediately prior to start. Typically, the experiment was carried out for 3 runs of 2 




QD-HTL UV-Vis Absorption and Photoluminescence Spectra 
Absorption spectra were measured on a Shimadzu UV-2401PC scanning 
spectrophotometer. Photoluminescence spectra were measured on a spectrofluorometer 
from Photon Technology International with a xenon excitation lamp and photomultiplier 
tube detector.  
TEM Imaging 
TEM imaging was used to validate the size of the QDs after synthesis. Briefly, 5 
µl of QD sample was pipette onto a carbon TEM grid. After 15 minutes, the solvents 
were slowly wicked away with filter paper. For visualization of the polymer shell, 
samples were counterstained with a 1% phosphotungstic acid solution (pH 6) for 30 
seconds. Again, the staining solution was slowly wicked away with filter paper and 
allowed to dry. TEM grids were imaged on a Hitachi H-7500 Transmission Electron 
Microscope at an acceleration voltage of 80 kV.  
QD-HTL and HTP Gel Electrophoresis Binding Assays 
Samples were resolved using a 1% (w/v) agarose gel in 50 mM borate buffer (pH 
8.5). Briefly, 250 mg of agarose (EMD Biosciences) was weighed into a 250 ml beaker, 
to which 50 ml of 50 mM borate buffer was added. The solution was heated in a 
microwave until completely dissolved, and subsequently cast into a gel electrophoresis 
tray with a 1.5 mm 15 well comb. Meanwhile, QD-HTLs samples were incubated with 
HaloTag protein (HaloTag standard protein, Promega Corporation) or an equivalent 
concentration of cell lysate (non-denatured U2OS cell lysate, Abnova) in mg/ml.  
Samples were allowed to incubate for 30 min at room temperature from the start of 
incubation to the start of the electrophoresis run, unless indicated otherwise. Once the gel 
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solidified, it was loaded into a gel electrophoresis tank (Mini-SubCell GT, Bio-Rad) and 
fully submerged in 50 mM borate buffer as the running buffer. 18 µl of sample was 
loaded into each well along with 2 µl of 10x borate loading buffer (500 mM borate, 25% 
v/v glycerol, 0.25% w/v Orange-G dye). Gels were run for 20 minutes at 100 V using a 
Bio-Rad Power Pac Basic and imaged using a Bio-Rad Gel Reader.   
4.3 Results and Discussion 
Quantum Dot-HaloTag Ligand Development and Conjugate Design 
Thus far, there have only been a few literature reports employing HaloTagged 
nanoparticles for cellular studies. The HaloTag-nanoparticle conjugates used in these 
studies have mainly been assembled using commercially available nanoparticles. The 
first study, performed by So et. al, utilized commercial streptavidin-QDs coupled to 
biotinylated HaloTag ligands [125]. A second study performed by Liβe et al. reported 
great difficulties with nonspecific binding when using commercially available QDs. 
Unable to achieve any specific cellular staining with QDs, the authors chose instead to 
conjugate HTLs to commercially available dye-loaded polystyrene nanoparticles. These 
fluorescent nanoparticles were coupled to HTLs using click chemistry by reacting 
dibenzocyclooctyne-functionalized fluorescent nanoparticles to azide-functionalized 
HTLs [149].  
We sought to improve upon these existing methods by (1), using smaller QDs 
than currently available on the commercial market and (2), attaching the HTL directly to 
the QD without the presence of any bulky intermediate groups. Instead of using a non-
covalent conjugation strategy like the biotin-streptavidin interaction, we sought to attach 
the HTL covalently to the QD surface. We further sought to reconcile some of the 
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differences between the studies performed by So and Liβe by investigating whether 
changes in surface parameters such as linker length play a role in determining binding 
specificity.   
Our multidentate polymer coated QDs serve as an ideal “size-minimized” 
alternative to commercial, amphiphilic polymer coated QDs. Our lab has previously 
shown that a multidentate polymer coated QD is roughly only half the size of an 
amphiphilic polymer coated QD of the same wavelength and core size. Furthermore, the 
multidentate polymer contains several convenient functional groups readily available for 
bioconjugation [51], as shown in Figure 3.7c. For example, a red CdSe(CdS/CdZnS/ZnS) 
quantum dot coated with multidentate polymer contains roughly twenty amines, twenty 
thiols, and tens of thousands of carboxylic acids available for conjugation. 
Although many available options exist for covalent conjugation with these 
functional groups, we chose to react nitrophenol carbonate terminated HaloTag ligands 
with QD surface amines to produce the QD-HTL (Figure 4.1). Nitrophenol carbonate is a 
good choice for several reasons—it hydrolyzes slowly and is compatible for use in both 
aqueous and organic solvents. Moreover, the stability of the urethane linkage under 
stringent conditions has already been demonstrated [148]. One especially fortuitous 
advantage is that the absorbance of the yellow 4-nitrophenol byproduct, which absorbs 
strongly at 400 nm, can be used to monitor the kinetics of the reaction between the HTL 
and QD. By choosing to react the HTLs with the surface amines, the tens of thousands of 






Figure 4.1. Reaction chemistry between nitrophenol carbonate HaloTag ligands and QD 
surface amines. “D” = HaloTag ligand. “R” = Multidentate polymer coated QD. Figure 




Despite the fact that the chloroalkane linker on Promega’s fluorescent dye-
HaloTag ligand conjugates is only ~250 g/mol in molecular weight (MW), preliminary 
evidence from several sources [40, 125, 149] has suggested that chloroalkane linkers of 
longer lengths should be used with nanoparticles to reduce steric hindrance of binding. 
The longest commercially available ligand, the Promega O4 succinimidyl ester ligand, is 
roughly 500 MW. We chose two more ligands of higher molecular weights, 700 and 2500 
MW, to investigate the effects of linker length on HaloTag binding ability. As shown in 
Figure 4.2, the 6-carbon chloroalkane group remains constant for each HaloTag ligand, 
with any differences in ligand length arising predominantly from changes in the length of 


















Figure 4.2. Structure of HaloTag ligands. (a) 700 MW Nitrophenol Carbonate HaloTag 
ligand (697.16 g/mol) (b) 2500 MW Nitrophenol Carbonate HaloTag ligand (2503.35 




Multidentate Polymer Quantum Dot Synthesis and Characterization 
Red CdSe(CdS/CdZnS/ZnS) QD of 629 nm emission were synthesized and used 
throughout the work. The absorption and emission spectra of the synthesized QDs are 


























Figure 4.3. Normalized absorption and emission spectra of CdSe(CdS/CdZnS/ZnS) QDs. 





As shown in Figure 4.4, a TEM image of the synthesized QDs shows that the QDs 
are fairly monodisperse. An analysis of 100 particles in the TEM image indicates that 
these QDs have an average size of 6.1 nm. This size is in close agreement with the 
theoretical diameter of predicted by known correlation with the first exciton peak. A 
summary of the properties of the QDs prior to multidentate polymer coating can be found 





















Table 4.1. Composition and spectral properties of CdSe(CdS/CdZnS/ZnS) QDs prior to 





Upon coating the QD with multidentate polymer in DMSO, QDs were phase 
transferred to aqueous solution for subsequent conjugation reactions. Coating with 
multidentate polymer and subsequent phase transfer to water produced no significant 
changes to the absorption and emission spectra of the QDs. The average hydrodynamic 
size of the polymer coated QD in PBS was determined to be 7.5 nm as measured by DLS 
(Figure 4.14).  
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Quantum Dot Surface Functionalization with Nitrophenol Carbonate Ligands 
We chose to modify the QD with the HaloTag ligand after coating the surface 
with the multidentate polymer, rather than making ligand modifications to the polymer 
prior to coating the QD. The former method grants us more precise control over the exact 
surface chemistry and helps ensure that the functional groups of the conjugated ligands 
do not interfere with the coating process. We also chose to carry out conjugation 
reactions in aqueous solution rather than DMSO, as multidentate polymer coated QDs 
were observed to have greater long term stability in water than organic solvent.  
Reactions between QD and nitrophenol carbonate terminated HaloTag ligands 
were performed in aqueous solution at room temperature at pH 8.5. The basic pH is 
crucial for ensuring the QD surface amines are deprotonated for the reaction to proceed. 
By monitoring the kinetics of the release of the nitrophenol group, we found that the 
reaction between QD and HaloTag ligand reaches equilibrium in 18-20 hours under these 
conditions (Figure 4.5). Henceforth, HTLs were allowed to react with QDs for at least 20 















Figure 4.5. Reaction kinetics of nitrophenol carbonate HaloTag Ligands to multidentate 
polymer coated QDs. Reaction was performed with a ten-fold molar excess of 2500 MW 
nitrophenol carbonate ligand to QD at room temperature and pH 8.5, with a final QD 




As previously stated, the reaction was carried out in aqueous solution due to the 
increased long term stability of multidentate polymer QDs in water. However, one 
disadvantage of performing an aqueous reaction is that the nitrophenol carbonate ligand 
hydrolyzes much more rapidly in water than in organic solvent. To address this issue, 
nitrophenol carbonate ligands were first diluted to in anhydrous DMSO to the appropriate 
concentration before addition to an aqueous solution of QDs. The amount of DMSO 
added to the reaction volume was optimized accordingly. When the amount of ligand in 
DMSO added was less than 10% of the final reaction volume, we found that the ligand 
hydrolyzed too rapidly for efficient reaction to occur. On the contrary, if the amount of 
ligand added exceeded 20%, the resulting QD-HTL conjugates were difficult to purify 
due to the incompatibility of many purification membranes with high concentrations of 
DMSO. Henceforth, we made sure the amount of ligand added during reaction was 
between 10-15% of the final reaction volume.  
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Purification of Quantum Dot-HaloTag Ligand Conjugates  
The purpose of purifying the resulting QD-HTL conjugates is to remove any 
unreacted ligand as well as 4-nitrophenol by-product. Removing unreacted ligand is 
essential as free ligands will compete against QD-HTLs for binding with HTP, and 
excess nitrophenol may cause toxicity to cells.  
Two different methods were examined for the purification of QD-HTL 
conjugates: ultrafiltration and dialysis. Both methods rely on a size difference between 
the sample and by-product as the basis for purification, utilizing a porous membrane and 
a driving force for removal of by-products. Ultrafiltration is a popular method in the 
literature for purifying free ligand from QD, and is also the method of choice employed 
by So et al. to remove unreacted biotinylated HTLs from streptavidin-QDs [53, 125, 
127]. Like So, we chose to use the 10K Nanosep filter available from Pall Lifesciences, 
which utilizes centrifugation as the driving force for purification. In this device, buffer 
containing the QD-HTL sample is loaded on top of a porous membrane. During 
centrifugation, molecules smaller than the molecular weight cutoff are eluted through the 
membrane, while the QD-HTLs are retained at the top of the membrane. Dialysis uses an 
osmotic pressure gradient for removal of unwanted by-products. Samples are loaded into 
a semi-permeable membrane and placed in a large tank of buffer, allowing small by-
products to diffuse out of the membrane according to their concentration gradient. For 
dialysis, we used 20K MWCO Slide-a-lyzer Mini Dialysis Devices available from 
Thermo Scientific Pierce.  
In both of these methods, selection of an appropriate molecular weight cutoff is 
critical. In general, the MWCO should be at most half the molecular weight of the 
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product to be retained and at least twice the molecular weight of the product to be 
removed [150]. According to Fast Performance Liquid Chromatography (FPLC) studies 
comparing the size of our multidentate polymer QD to protein standards of known 
molecular weight, a QD with 7.5 nm hydrodynamic diameter roughly corresponds to a 
molecular weight of 100 kDa. Thus, a molecular weight cutoff of 10-20 kDa was well-
suited for removing 2500 MW HaloTag ligands and smaller by-products from the QD-
HTL conjugates.  
Both ultrafiltration and dialysis have their advantages and disadvantages. 
Ultrafiltration has the advantage of being a rapid procedure, allowing purification to be 
completed in less than an hour. However, centrifugation can be relatively harsh on the 
nanoparticles, and special care was taken to minimize the speed of centrifugation as much 
as possible. We found that repeated centrifugation (6 or more repetitions) can result in a 
moderate amount of aggregation. In general, we tried to limit the QD-HTL conjugates to 
at most 4 rounds of centrifugation. When present, aggregates could be pelleted and 
removed by centrifugation at 7500 rpm or by passing the sample through a 0.2 µm 
syringe filter.  
In contrast, dialysis is a far gentler procedure, resulting in little to no aggregation. 
Dialysis has the disadvantage of being a time consuming process, requiring several buffer 
changes over several days to achieve the same purity as ultrafiltration. Moreover, dialysis 
requires several liters of buffer, making it a potentially expensive process if dialyzing into 
special buffers other than water or PBS.  
Figure 4.6 depicts the difference between QD-HTL conjugates purified using 
these two purification procedures. In this experiment, QD-HTL conjugates were purified 
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with either ultrafiltration or dialysis and then incubated with HTP for 30 minutes. The 
samples were subsequently resolved using agarose gel electrophoresis, a technique for 
separating macromolecules based on their size and charge. Due to the negative zeta 
potential of the multidentate polymer QDs, QD-HTLs migrate to the cathode, located at 
the bottom of the gel image. Binding to HTP results in slower migration and a band shift 
towards the anode due to an increase in size and reduced charges from protein shielding.  
QD-HTL conjugates purified by ultrafiltration produced broad, smear-like bands 
in gel electrophoresis. Interestingly, other researchers have likewise observed this smear 
when performing gel electrophoresis with QD conjugates purified by ultrafiltration [127]. 
While Petershans and coworkers had attributed the smear to broad distributions in the 
number of proteins bound to the QD surface, our experiments indicate that the smear can 
be almost entirely abolished by changing the purification procedure to dialysis. While the 
exact reason for smearing remains unknown, it is possible that the centrifugation process 
may introduce slight rearrangements to the QD coating, causing a change in the size 
distribution of some of the particles. Nonetheless, ultrafiltration does not seem to 
adversely affect QD-HTL binding ability, and conjugates purified by ultrafiltration still 

















Figure 4.6. Agarose gel images comparing QD-HTL conjugates purified with different 
purification methods. QD-HTL conjugates were purified via (a) ultrafiltration, and (b) 
dialysis. In each gel image, QD-HTLs in leftmost lane are exposed to increasing amounts 




Effect of HaloTag Ligand Length on HaloTag Protein Binding Ability 
Preliminary evidence from the literature suggests that the HaloTag ligand 
length—i.e. the length of the linker between the QD and the terminal chloroalkane 
group—can have a significant effect on the binding capability of the QD-HTL. So and 
coworkers utilized biotinylated HTLs of two different lengths, roughly 610 MW and 730 
MW, that differed from each other by only 2 ethylene glycol repeats. They found that 
QD-HTLs comprised of the longer ligand had better water solubility, resulting in better 
cellular labeling efficiency, whereas QD-HTLs made using the shorter ligand tended to 
aggregate easily [125].  
Studies performed by Liβe et al. also seem to suggest that the length of the 
HaloTag ligand may affect the binding rate constant. Liβe and coworkers compared two 
different nanoparticle-HTL conjugates, one functionalized with Promega’s HaloTag thiol 
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O4 ligand, and one functionalized with a novel click-chemistry-based HTL. By 
monitoring the real time kinetics of HTP binding, they showed that the click-chemistry-
based HTL exhibited a 10-fold faster binding reaction rate than the thiol-HTL. Although 
the authors attributed the difference in reaction rate to the presence of the hydrophobic 
“click” moiety, which they argue helps to stabilize the HaloTag enzyme-substrate 
complex, we noted that a difference in ligand length may be partially responsible for the 
improved reaction rate [149]. The Promega HaloTag thiol O4 ligand is only about 330 
Da, whereas Liβe’s novel click-based ligand is over 1400 Da in molecular weight. 
However, the authors did not independently examine the effects of ligand length and the 
presence of the click group on the binding reaction rate constant. We hypothesized that 
the increased ligand length could facilitate binding of the QD-HTL to HTP by reducing 
the effect of steric hindrance.  
Our preliminary results suggested that chloroalkane ligands with long ethylene 
glycol linkers are indeed more effective at binding HaloTag protein (HTP) than their 
shorter counterparts. When commercially available succinimidyl ester O4 HTLs of ~500 
MW (4 ethylene glycol repeats) were conjugated to multidentate polymer coated QDs, 
little binding to purified HTP could be detected. Figure 4.7 shows the results of a gel 
electrophoresis assay performed to assess the binding capacity of QDs conjugated to 
these succinimidyl ester O4 ligands. HTLs were reacted with QDs at a molar reaction 
ratio ranging from 1 to 100 ligands per QD, as denoted in green. In the presence of 
HaloTag protein (Lanes #6 – 9), most QD-HTL conjugates remain unbound to protein, 
and there is little evidence of a band shift to indicate protein binding. This holds true 
regardless of the number of ligands on the QD surface. As shown on the right-hand side 
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of Figure 4.7, the controls consist of QDs without any HaloTag ligands on their surface. 























Figure 4.7. Gel electrophoresis mobility assay assessing the binding ability of QDs 
conjugated to O4-succinimidyl ester 500 MW HaloTag ligands. QDs were reacted with 
500 MW HTLs at the HTL:QD molar ratio indicated in green. Resulting QD-HTLs were 




In contrast, both 700 MW HTL (8 ethylene glycol repeats), and 2500 MW HTL 
(~50 ethylene glycol repeats) show effective binding to purified HTP upon QD 
conjugation. Figure 4.8 shows the results of an electrophoresis assay performed to 
simultaneously assess the effects of HaloTag ligand length and ligand density on QD-
HTL binding capacity. Three different ligand densities (1:1, 5:1, and 20:1 HTL:QD) were 
studied for two ligand lengths (700 and 2500 MW). The controls are comprised of QDs 
 70 
without any HaloTag ligands on their surface. In the presence of HaloTag protein, control 
QDs exhibit minimal nonspecific binding (Lane #8).  
As shown in Figure 4.8, a band shift can be clearly seen when the QD-HTLs are 
incubated with HaloTag protein (Lanes #4 – 6). This shift is evident for both 700 and 
2500 molecular weights, even when only one HaloTag ligand per QD is present (Lane 
#4). In these lanes, QD-HTLs that are bound to HTP can be clearly distinguished from 
those that remain unbound. In conclusion, both 700 and 2500 MW ligands retain their 
ability to bind soluble HaloTag protein specifically when conjugated to QDs. This holds 
true, even for low ligand densities down to one ligand per QD.  
 
 
Figure 4.8. Gel electrophoresis mobility assay assessing quantum dot-HaloTag ligand 
(QD-HTL) conjugates of various ligand lengths and ligand densities. (A) QD-HTL 
conjugates with 700 MW HaloTag ligands. (B) QD-HTL conjugates with 2500 MW 
HaloTag ligands. QDs were reacted with HTLs at the HTL:QD molar ratio indicated in 
green. Resulting QD-HTLs were subsequently incubated with HaloTag protein at the 





Multidentate polymer coated QDs exhibited reasonably little nonspecific binding 
when incubated with less than 5 fold excess HTP for 30 minutes at RT. Nonetheless, 
Figures 4.7 and 4.8 still demonstrate that a small amount of nonspecific binding is always 
present. Due to the negative zeta potential of the QDs, we found that nonspecific binding 
became increasingly significant when incubated with larger amounts of HTP, especially 
at prolonged time periods or at elevated temperatures. In addition, nonspecific binding of 
the QD-HTL conjugates to cell lysate was nontrivial. Because this nonspecific binding 
could cause potential problems in cellular studies, we decided to investigate the effect of 
incorporating small molecular weight PEG chains into the surface coating. For studies 
involving pegylated QD-HTLs, the longer 2500 MW ligand was used to allow greater 
flexibility in the length of PEG chain that can be grafted on the QD-HTL surface.  
Pegylation of Quantum Dot-HaloTag Ligand Conjugates  
Polyethylene glycol is very widely used in biomedical applications to reduce the 
nonspecific binding of nanoparticles, medical implants, and drug delivery vehicles, etc. 
[151, 152]. As such, linear amine-terminated PEGs of three different sizes, 370, 1000, 
and 2000 MW were grafted onto QD-HTLs and investigated for their ability to reduce 
nonspecific binding while still providing adequate binding capacity. In these studies, 
amine-terminated PEGs were conjugated to the carboxyl groups of the multidentate 
polymer coating using carbodiimide chemistry. 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide (commonly known as EDC) was used as the carbodiimide of choice 
because of its solubility in water. Unfortunately, initial attempts to with PEG using EDC 
resulted in QD instability and precipitation out of solution in as little as 24 hours.  
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To optimize the pegylation procedure, parameters affecting the stability of the 
PEG-QD conjugates were investigated. The amount of EDC (1,000 to 100,000 molar 
excess) and PEG (5 to 200,000 molar excess) used to pegylate the QD was varied, and 
the stability of the QD was monitored for at least one week. We also sought to determine 
whether the MES buffer used for the pegylation reaction had any effect on the stability of 
the QDs over time when compared to PBS buffer.  
We found that excessive EDC was responsible for the instability of the QDs 
[153]. When the amount of EDC added exceeded the amount of PEG added, QDs would 
precipitate out of solution over time. Conversely, QDs would remain stable for several 
months if the amount of EDC was less than the amount of PEG added regardless of the 
length or amount of PEG used. We found that a molar ratio of 0.75:1 EDC to PEG was 
ideal for producing stable pegylated QDs, and found this value to be fairly consistent 
with previous reports [154]. Moreover, both pegylated and nonpegylated multidentate 
polymer QDs were able to remain stable in MES and PBS buffers for several months.  
Activation of carboxylic acids with EDC occurs most efficiently in the pH 4.5- 
7.2 range. As a result, EDC reactions are typically carried out in MES buffer (pH 6), 
although reactions in buffers of higher pH such as PBS or borate can also be performed 
[72, 154]. We tested the pegylation of our multidentate polymer QDs in both MES and 
PBS buffers and found that reaction in PBS produced pegylated particles of much greater 
size distribution. When resolved using agarose gel electrophoresis, QDs pegylated in PBS 
produced broad smear-like bands whereas QDs pegylated in MES produced more 
compact bands indicating a greater degree of monodispersity (Figure 4.9). Henceforth, all 
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pegylation reactions were carried out in MES, and pegylated QDs were subsequently 











Figure 4.9. Agarose gel comparing QDs pegylated in MES buffer (pH 6) versus PBS 




For each length of PEG, we sought to determine (a), the amount of PEG needed to 
fully coat the QD surface under the given reaction conditions and (b), whether the PEG 
coating would be sufficient for fully neutralizing the surface. As shown in Figure 4.10, 
both 2000 and 1000 MW PEGs were able to fully neutralize the surface, preventing the 
QD from migrating out of the well during gel electrophoresis. Roughly 5000 excess of 
2000 MW PEG or 10,000 excess of 1000 MW PEG was required to fully coat the QD 
surface. In contrast, 370 MW PEGs were unable to prevent electrophoretic movement out 
of wells, even when coated at 200,000 molar excess. This observation is consistent with 
results reported by Bentzen and coworkers, who likewise reported electrophoretic 
movement out of wells for amphiphilic polymer coated QDs fully coated with 350 MW 





Figure 4.10. Gel electrophoresis mobility assay examining QDs coated with different 
PEG densities and molecular weights. QDs were reacted with various molar excesses of 
370, 1000, and 2000 MW PEG, as indicated in blue. For example, “5 K” indicates that 




Preliminary studies indicated that 2000 MW was the maximum PEG length that 
could be grafted onto the QD surface while still allowing QD-HTL conjugates composed 
of 2500 MW HaloTag Ligands to specifically bind to purified HaloTag protein. Figure 
4.11 shows the results of an electrophoresis assay that was performed to simultaneously 
assess the effects of PEG coverage and HaloTag ligand density on QD-HTL binding 
capacity. Varying amounts of 2000 MW PEG ranging from 5,000 to 50,000 excess were 
used to coat QD-HTLs containing three different surface ligand densities (50:1, 5:1, and 
1:1 HTL:QD molar incubation ratios). As shown on the far right-hand side of Figure 
4.10, the controls are comprised of pegylated QDs without any ligands on their surface. 
In the presence of HaloTag protein, pegylated QDs without ligand exhibit minimal 
nonspecific binding (Lanes #22 – 24).  
For pegylated QD-HTL constructs that have been coated with an excess of 5,000x 
or 10,000x PEG, a distinctive band shift can be seen in the presence of HaloTag protein, 
regardless of the ligand density (Lanes #5, 6, 11, 12, 17, 18). This shift, however, cannot 
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be seen for pegylated QD-HTL constructs that have been coated with 50,000x PEG. One 
important conclusion, therefore, is that the pegylated QD-HTL can lose its ability to bind 
target protein if the amount of PEG coverage on the surface is too great. One promising 
observation is that QD-HTLs of low ligand density, down to 1:1 HTL:QD, can still bind 
their target when pegylated, provided that the degree of pegylation is not too excessive. 
These studies indicate that the surface chemistry of the quantum dot plays a very 
important role in influencing the binding interaction between the HaloTag ligand and the 




Figure 4.11. Gel electrophoresis mobility assay assessing pegylated quantum dot-
HaloTag ligand (QD-HTL) conjugates of various ligand densities and amounts of 2000 
MW PEG. QDs were reacted with 2500 MW HaloTag ligands at the HTL:QD molar ratio 
indicated in green. QDs were subsequently coated with 2000 MW PEG at the PEG:QD 
molar ratio indicated in blue. The final PEG-QD-HTL conjugates were incubated with 




Pegylated QD-HTLs fully coated with 1000 MW PEG behave in much the same 
way as pegylated QD-HTLs fully coated with 2000 MW PEG. As shown in Figure 4.12, 
QD-HTLs coated with 10,000 excess 1000 MW PEG remain capable of binding HTP, 
while control pegylated QDs show minimal nonspecific binding to HTP. Pegylated QD-
HTLs fully coated with either 1000 or 2000 MW PEG also remain resistant to 
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nonspecific binding when added to U2OS cell lysate (Figure 4.13). In contrast, we found 
that pegylated QDs and pegylated QD-HTLs fully coated with 30,000x 370 MW PEG 















Figure 4.12. Gel electrophoresis mobility assay assessing HaloTag binding ability of 
quantum dot-HaloTag ligand (QD-HTL) conjugates of various ligand densities coated 
with 10,000 excess 1000 MW PEG. QDs were reacted with 2500 MW HaloTag ligands at 
the HTL:QD molar ratio indicated in green. Upon coating with 1000 MW PEG, the 
resulting PEG-QD-HTL conjugates were incubated with HaloTag protein at the HTP:QD 





Figure 4.13. Agarose gel image depicting nonspecific binding of PEG-QD-HTL 
conjugates to cell lysate. (a) QD-HTL conjugates coated with 5000 excess of 2000 MW 
PEG and (b) QD-HTL conjugates coated with 10,000 excess of 1000 MW PEG are 
incubated either in PBS or cell lysate for 1 hour.  
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In summary, 1000 MW PEG and 2000 MW PEG coatings were able to fully 
abolish electrophoretic mobility of QDs during gel electrophoresis, whereas QDs coated 
with 370 MW PEG always retained their ability to migrate out of wells. Accordingly, 
1000 MW PEG and 2000 MW PEG coatings were more effective at reducing nonspecific 
binding than 370 MW PEG coatings.  
Characterization of Quantum Dot-HaloTag Ligand Conjugates  
Multidentate polymer QD-HTL conjugates remain exceptionally compact, even 
after surface modification with PEG. Due to the limitless number of possible surface 
variations in the number of ligands, length of ligand, degree of PEG coating, and length 
of PEG, we sought to focus our characterization studies on QDs functionalized with 2500 
MW ligand and coated with 10,000 excess of 1000 MW PEG. This combination was 
found to be ideal for cell staining, as later discussed in Chapter 5. As shown in Figure 
4.14, a multidentate polymer coated CdSe(CdS/CdZnS/ZnS) QD with 629 nm emission 
that is originally 7.5 nm in hydrodynamic diameter (i) becomes an average of 8.5 nm in 
hydrodynamic diameter after surface modification with two-fold excess 2500 molecular 
weight HTL (ii). After complete coating with 10,000 excess 1000 MW PEG, the final 
PEG-QD-HTL conjugate reaches an average hydrodynamic diameter of 12 nm (iii), 
which is significantly smaller than conventional pegylated QDs, which typically range 
from 25-35 nm [155]. Modification of QDs with HTL and PEG did not result in any 





















Figure 4.14. Hydrodynamic size of QD-HTLs before and after HaloTag ligand 
conjugation and PEG modification. Dynamic light scattering data of multidentate 
polymer coated QDs (i, red); multidentate polymer coated QDs reacted with 2-fold molar 
excess 2500 MW HTL (ii, green); multidentate polymer coated QDs reacted with 2-fold 




To estimate the number of PEGs on the surface of the quantum dot, we coated the 
multidentate polymer with PEG containing a terminal fluorescein dye. This strategy has 
been utilized by multiple researchers to quantitate the number of PEGs on nanoparticle 
surfaces [152, 156, 157]. Although this strategy is not entirely accurate because the 
fluorescein group adds a small amount of extra molecular weight (300 Da) to the PEG, it 
nonetheless provides a good estimate of the number of PEGs on the QD surface. A 
similar alternative strategy for quantifying the number of PEG molecules is to coat the 
nanoparticle with PEG containing a specific terminal functional group such as a thiol or 
amine. A fluorometric or colorimetric agent such as fluorescamine or Ellman's reagent 
can then be used to determine the number of functional group, and hence, the number of 
PEG molecules on the nanoparticle surface [158]. While eliminating problems with the 
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added molecular weight of the dye, this method is more difficult in our case due to the 
presence of thiols and amines in the multidentate polymer coating the QD. Nuclear 
magnetic resonance (NMR) can also be used to detect the ethylene protons on the 
nanoparticle surface, but this method is not as quantitative and requires large quantities of 
nanoparticles for analysis [152, 159].  
In our strategy, red CdSe(CdS/CdZnS/ZnS) QDs were reacted with 10,000 excess 
of 1000 MW FITC-PEG (green) and 7,500 M EDC and subjected to extensive dialysis. 
An identical sample of QDs and PEG was prepared without EDC and purified alongside 
the FITC-PEG-QD as a control to ensure complete removal of FITC-PEG. For 
determining the number of FITC-PEG molecules, absorbance measurements are preferred 
over fluorescence intensity measurements due to possible effects of self-quenching when 
fluorescent molecules are present in high concentrations [160]. Figure 4.15 shows the 
UV-Vis spectrum of these samples after purification. The presence of a large absorbance 
peak at 490 nm indicates that FITC-PEG was indeed successfully conjugated to the QD 
surface (green). A comparison of the spectra of the control sample (blue) with a sample 
of multidentate polymer QDs (red) indicates that FITC-PEG was completely removed 
during purification. By using Beer’s law and the extinction coefficient of FITC-PEG, the 



























Figure 4.15. Estimation of the number of PEG molecules on the QD surface using FITC 
dye absorbance. QDs are reacted with 10,000 excess 1000 MW PEG containing a 
terminal FITC dye. Upon thorough purification of unreacted FITC-PEGs, the absorption 
spectrum of the FITC-PEG-QD conjugates (green) is compared with the absorption 
spectrum of QDs alone (red). The control (blue) contains a sample of QDs and 10,000 
excess FITC-PEG without EDC that has been subjected to the same purification as the 




It is important to characterize the number of ligands on the QD surface to ensure 
that an increase in the number of HTLs reacted with QD actually results in an increase in 
valency on the nanoparticle surface. To estimate the number of ligands on the QD 
surface, we utilized a fluorescamine assay to measure the number of prior amines on the 
QD surface prior to and after to reaction with nitrophenol carbonate HTLs. 
Fluorescamine is a nonfluorescent compound that reacts with primary amines to form a 
highly fluorescent compound that emits at 470 nm [161]. One major advantage of using 
fluorescamine over absorbance based detection methods is that purification of excess 
fluorescamine is unnecessary due to the nonfluorescent nature of unreacted 
fluorescamine. Indeed, complete purification of unreacted dyes is extremely challenging 
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and artifacts can arise in absorbance data if purification is not consistently uniform across 
multiple samples. However, with all fluorescence based assays, special care should be 
taken to avoid self-quenching at high dye concentrations and to prevent photobleaching 
by working in the dark. In addition, special care must be taken when designing the 
experiment to account for possible fluorescence resonance energy transfer (FRET) effects 
between the QD and the fluorescent dye. 
For FRET to occur, three conditions must be satisfied. First, the donor and 
acceptor molecules must be in close proximity to each other, usually 1 to 10 nm apart. 
Second, the donor’s fluorescence emission spectrum must overlap with the acceptor’s 
absorption spectrum. One basic implication of this is that the donor must be at higher 
energy than the acceptor. Finally, the transition dipole orientations of the donor and 
acceptor must be approximately parallel [162]. Because fluorescamine’s emission at 470 
nm overlaps with the QD’s broadband absorption spectrum, fluorescamine could 
potentially serve as a FRET donor to a QD acceptor in our experiment. However, studies 
have shown that in general, fluorescence resonance energy does not transfer from a donor 
dye to an acceptor QD due to the fast radiative decay of the dye and the much longer 
exciton lifetime of the QD [163]. We tested this by adding increasing amounts of 
fluorescamine to a sample of QDs to see if there were any increases in QD fluorescence 
intensity, and found no evidence of FRET between the dye and QD.  
To perform the assay, fluorescamine was first added to a standard of glycine 
molecules to determine the linear dynamic range for reaction with primary amines. The 
dynamic range was found to be linear for amine concentrations ranging from 250 nM to 
10 µM, similar to previously reported results (Figure 4.16, left) [53]. Fluorescamine was 
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then added to multidentate polymer coated QD-HTL conjugates that had been reacted 
with 0, 5, 10, and 20 fold molar excess HTL. 
 
 
Figure 4.16. Estimation of the number of HaloTag ligands on the QD surface using a 
fluorescamine assay. A series of glycine standards are first reacted with fluorescamine to 
determine the linear dynamic range for detection of primary amines (left). Immediately 
afterward, QD-HTL conjugates with are reacted with fluorescamine to determine the 
number of free amines on the QD-HTL surface (right). The number of HTLs on the QD 
surface can be determined by subtracting the number of free amines on the QD surface 




The right hand side of Figure 4.16 shows the results of a fluorescamine assay for 
QD samples assayed at 600 nM concentration. As expected, QDs without HTL have the 
highest fluorescamine signal intensity, while signal intensity progressively decreases for 
QD-HTLs containing increasing amounts of ligand on the surface. Since the nitrophenol 
carbonate HTL reacts with primary amines on the multidentate polymer QD coating, QD-
HTLs with higher ligand content have fewer amines available for reaction with 
fluorescamine. As measured by the fluorescamine assay, red multidentate polymer coated 
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CdSe(CdS/CdZnS/ZnS) QDs that are 7.5 nm in hydrodynamic diameter have roughly 16-
17 amines on the surface prior to ligand conjugation.  
Table 4.2 and Table 4.3 list the average number of ligands empirically determined 
or interpolated for QD-HTL conjugates of various ligand densities. The results of this 
assay indicate that the number of ligands on the QD surface is fairly consistent with the 
number of ligands incubated with QD during reaction. For example, QDs reacted with 
HTL at a 1:1 molar ratio have roughly 1 ligand on the surface on average.  
 
 






Table 4.3. Interpolated data from a fluorescamine assay for estimating the number of 












This data is helpful for determining an appropriate molar reaction ratio for 
producing monovalent QD-HTLs for single-molecule imaging. Since the number of 
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ligands present on the QD surface is governed by a Poisson distribution, HTLs should be 
incubated with QDs at a HTL:QD ratio much less than 1 in order to produce monovalent 
QDs. At low ratios such as 0.5:1 HTL:QDs or smaller, most QDs will only contain 1 or 0 
ligands on their surface, with a very low probability of QDs containing 2 or more ligands 
on their surface. In conclusion, the results of this fluorescamine assay indicate that HTLs 
can indeed be reacted with QDs at a well controlled stoichiometries required for live cell 
imaging.  
4.4 Conclusions 
We have developed a new strategy for HaloTagging of QDs based on the use of 
size-minimized multidentate polymer coated QDs. We have optimized synthesis and 
purification procedures for these QD-HTLs and further characterized their binding to 
purified HTP. These QD-HTLs demonstrate efficient binding to purified HTP when 
elongated HaloTag ligands of 700 and 2500 MW are utilized. Furthermore, these QD-
HTLs are able to bind HTP even at low ligand densities, potentially down to 1 HTL per 
QD. These QD-HTLs retain their ability to bind HTP specifically even when coated with 
PEG, provided that the degree of pegylation is not too excessive. In conclusion, our 
studies show that QD surface chemistry plays an important role in the interaction 
between the QD-HTL and the HTP, and that QD binding to target protein can be 






SPECIFIC AND NONSPECIFIC BINDING OF QUANTUM DOT-
HALOTAG LIGAND CONJUGATES TO CELLULAR SURFACES 
 
5.1 Introduction 
In order to be useful for cellular imaging applications, quantum dot probes must 
be able stain desired proteins of interest both specifically and efficiently. Especially for 
single-molecule imaging, nonspecific binding must be reduced as much as possible to 
prevent tracking of unintended proteins. Nonetheless, eliminating nonspecific binding has 
always been a fundamental challenge for all types of colloids due to their high surface 
energy and large available surface area for binding.  
In Chapter 4, we have shown that Quantum Dot-HaloTag ligand conjugates are 
able to specifically bind purified HaloTag proteins in solution. While many trends are 
anticipated to be similar to those observed with purified HaloTag proteins, binding to 
cellular HaloTag proteins is more complex due to the heterogeneity of cellular surfaces. 
Binding interactions are also expected to be more sterically hindered when constrained to 
a 2-D surface rather than a 3-D volume.  
In this chapter, we seek to identify the key parameters that govern the delicate 
balance between specific and nonspecific binding in the QD-HaloTag cellular system, 




5.2 Materials and Methods 
Cell Culture and Staining 
U2OS cells stably expressing HaloTag protein fused to the extracellular domain 
of β1 integrin (“U2OS-ECS1-HTP”) were a generous gift from Promega Corporation. 
Details of their cloning and expression are extensively described by Svendsen et al. 
[137]. U2OS cells (ATCC #HTB-96) were maintained in McCoy’s 5A media 
supplemented with 10% FBS at 37 
0
C and 5% CO2. Stable U2OS-ECS1-HTP cells were 
maintained in McCoy’s 5A media supplemented with 10% FBS and 500 mg/ml Geneticin 
Sulfate at 37 
0
C and 5% CO2.  
For cell labeling, cells were plated on an 8-well Lab-Tek II chamber cover glass 
(Nunc) and allowed to grow to ~50% confluency for approximately 24 hrs. Prior to 
staining, cells were washed twice with imaging media consisting of phenol red-free 
McCoy’s 5A media supplemented with 20 mM HEPES. Cells were then incubated with 
TMR ligand or QD-HTL conjugates in imaging media for 15 min at 37 
0
C and 5% CO2. 
Afterward, cells were rinsed three times in imaging media at room temperature followed 
by a 15 minute incubation at 37 
0
C and 5% CO2, in accordance with the manufacturer’s 
recommended protocol [164]. Finally, the incubation media was replaced with fresh 
imaging media prior to fluorescence imaging.  
For studies examining the effect of ligand density on staining specificity, PEG-
QD-HTLs were applied to U2OS-ECS1-HTP cells (denoted as HTP+) and U2OS cells 
(denoted as HTP-) at a series of concentrations from 20 to 200 nM. For each ligand 
density, the concentration that resulted in greatest signal contrast between HTP+ and 
HTP- cells under the particular imaging conditions was selected for comparison. This 
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methodology accounts for the fact that QDs of lower ligand density require higher 
staining concentrations than QDs of higher ligand density to produce similar contrast. 
For studies examining the effect of PEG molecular weight on staining specificity, 
PEG-QD-HTLs were likewise applied to U2OS-ECS1-HTP and U2OS cells at a series of 
concentrations from 20 to 250 nM. When comparing PEG coatings of different molecular 
weight, the total mass weight of PEG used to completely coat the QD was kept roughly 
constant (i.e. molecular weight (g/mol) x molar excess = constant). As such, QD-HTLs 
were either coated with (a) 5,000 excess 2000 MW PEG (b) 10,000 excess 1000 MW 
PEG or (c) 28,000 excess 370 MW PEG. This methodology takes into consideration the 
fact that PEG polymers of longer lengths require fewer numbers to completely coat the 
QD surface.  
Live Cell Fluorescence Imaging 
Cells were imaged on an Olympus IX71 epifluorescence inverted microscope 
equipped with a Hamamatsu C9100 EM-CCD camera using a 20x objective. All samples 
were illuminated using a mercury arc lamp. The following filters were used for 
visualization of Promega TMR ligand (555 excitation/585 emission): 535/30 excitation, 
572 long pass emission, 565 dichroic. The following filters were used for visualization of 
QDs (629 emission): 330-385 excitation, 625/20 emission, 500 dichroic. Images were 





5.3 Results and Discussion 
TMR Ligand Staining of Cellular Surface HaloTag Protein 
Figure 5.1a shows a general schematic of the HaloTag expressing cells used 
throughout our studies. This cell line, known as “U2OS-ECS1-HTP”, expresses β1 
integrins with an extracellular domain that has been truncated and fused to the HaloTag 
protein. We selected this system because it has been previously used, thoroughly studied 
and well-characterized in the literature. Unlike many other surface display systems, the 
β1 integrin-HTP fusion has been shown to retain much of the activity of the original 
integrin. Svendsen et al. has shown that the β1 integrin-HTP fusion is localized, 
trafficked, and internalized in the same manner as native integrin, even undergoing the 
correct post-translational modifications [137]. β1 integrin plays critical roles in cell 
adhesion, invasion and migration [165, 166], and single-molecule studies could 
potentially uncover new insight on β1 integrin dynamics. Staining with TMR ligand, a 
commercially available fluorescent dye-HaloTag ligand conjugate from Promega, 
confirms that the β1 integrin-HTP is highly expressed and that the HaloTag protein 



















Figure 5.1. TMR staining of U2OS cells expressing a human β1 integrin-HaloTag fusion 
protein. Native human β1 integrin contains a cytoplasmic domain (CD), transmembrane 
domain (TM), extracellular domain (EC), and signal peptide (SP). U2OS-ECS1-HTP 
cells express a modified form of the β1 integrin, with the HaloTag protein fused to the 
truncated extracellular domain. (b) Chemical structure of TMR ligand. (c) Positive 
staining of U2OS-ECS1-HTP cells with 1 µM TMR ligand concentration. Images are 
shown at a dynamic range of 16000 units. Scale bar = 40 µm. 8a is adapted from [137]; 




Effect of Various Staining Conditions on HaloTag-Mediated Cell Staining  
HaloTag-mediated staining differs from traditional methods of cellular staining 
because of the enzymatic nature of the HaloTag protein. While the behavior of traditional 
labeling strategies is typically described by receptor-ligand kinetic equations, the 
HaloTag protein-HaloTag ligand reaction is governed by Michaelis-Menten kinetics.   
Enzymes typically require relatively high substrate concentrations for efficient 
reaction, and enzymatic activity is susceptible to changes in pH and temperature. In order 
to optimize the QD-HTL staining procedure, we first sought to qualitatively evaluate the 
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efficiency of the HaloTag labeling under various staining conditions, including different 
staining concentrations and temperatures, using the TMR ligand.  
Staining Concentration 
The Promega manufacturer’s protocol recommends staining at 5 µM TMR ligand 
concentration [164]. To see if a high substrate concentration was necessary for efficient 
enzymatic activity, we tested different staining concentrations ranging from 1 nM to 5 
µM. For all staining concentrations, the TMR ligand was able to specifically stain HTP 
expressing cells with respect to native cells (Figure 5.2). The fact that specific staining 
could be achieved at single-digit nanomolar concentrations served as promising evidence 
that HaloTag technology can be successfully applied to single-molecule tracking studies. 
Indeed, single-molecule imaging of an intracellular HaloTagged cAMP receptor using 
















Figure 5.2. Staining of HaloTag protein expressing (HTP+) cells and control (HTP-) 
cells at different TMR ligand concentrations. TMR staining at 1 nM concentration (left) 
is shown at 160x magnification and dynamic range of 500 units. Staining at 250 nM 
concentration (right) is shown at 32x magnification at a higher dynamic range of 8000 





Cells are often kept on ice or at 4 
0
C as a common method of preventing 
endocytosis of probes bound to cell surface receptors [168]. Studies have shown that 
shown that cellular metabolic processes, especially membrane internalization and 
receptor trafficking, are drastically slowed at lower temperatures [169, 170]. Hence, 
fluorescence staining of cell surface proteins is often performed at 4 
0
C to confine 
fluorescence signal to the perimeter of the cell. Staining at 4 
0
C also reduces endocytosis 
of nonspecifically bound probes. Once probes are internalized into vesicles, they cannot 
be removed. By confining nonspecifically bound probes to the cellular membrane surface 
where they can be washed away, lowered staining temperature may help to reduce 
nonspecific binding.   
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However, lowered temperature may also adversely affect enzymatic activity. The 
effect of temperature on reaction rates is governed by the Arrhenius equation,  
   Equation 5.1 
where k is the reaction rate constant, T is the absolute temperature in kelvins, A is a 
constant, Ea is the activation energy, and R is the universal gas constant, and T is the 
absolute temperature in kelvins. For enzymes, a general rule of thumb is that a 10 
0
C 
increase in temperature will increase the activity of most enzymes from one to two-fold, 
until the temperature exceeds the denaturation point of the enzyme [171]. Consequently, 
we sought to investigate the effect of staining temperature on the HaloTag protein-ligand 
enzymatic reaction.  
We performed cellular staining at both 37 
0
C and 4 
0
C and found that TMR ligand 
was able to specifically stain HaloTag protein expressing cells relative to control cells at 
both temperatures, as shown in Figure 5.3a. As expected, the enzymatic activity of the 
HaloTag protein was strongly temperature dependent, and the staining intensity of 
HaloTag protein expressing cells at 37 
0
C was over 6 times greater than the staining 
intensity at 4 
0
C (Figure 5.3b). Interestingly, we found that staining with TMR ligand at 
lowered temperature actually enhanced nonspecific binding to U2OS cells rather than 
reducing it (Figure 5.3c). We likewise observed a significant increase in nonspecific 
binding for QD-HTL conjugates at 4 
0
C compared to 37 
0
C (not shown). Our hypothesis 
is that lowered temperature reduces the diffusion of nonspecifically bound probes, 
making it more difficult to remove nonspecifically bound probes by washing. On the 
other hand, little endocytosis of TMR ligand was observed at 37 
0
C over the course of 15 
minutes. Because lowered temperature worsened staining contrast between HaloTag 
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protein expressing cells and control cells, we chose to perform all subsequent staining 








Figure 5.3. Effect of temperature on TMR ligand staining of HaloTag protein expressing 
(HTP+) cells and control (HTP-) cells. (a) TMR ligand exhibits specific staining to HTP+ 
cells with respect to control cells at both 37 
0
C and 4 
0
C. To depict contrast while 
avoiding signal saturation staining at 37 
0
C is shown over a different dynamic range than 
staining at 4 
0
C. (b) Specific staining of HTP+ cells at different temperatures is shown 
over a constant dynamic range of 6000 units. (c) Nonspecific staining of HTP- cells at 
different temperatures is shown over a constant dynamic range of 100 units. Scale bar = 
40 µm. Lowered temperature results in decreased positive staining to HTP+ cells and 






Nonspecific binding of QDs to cells has long been a major bottleneck in QD-
mediated cellular staining studies due to the high surface energy and large surface area of 
QDs [21]. As one strategy to prevent nonspecific binding, Dahan and Triller have 
reported that nonspecific binding of QD-antibody conjugates to cells can be reduced by 
staining in borate buffer at pH 8.5 supplemented with 215 mM sucrose to provide the 
proper physiological osmolarity [172, 173]. The slightly elevated pH reduces the 
reactivity of attached antibodies to nonspecific protein targets. An additional benefit is 
that QDs typically exhibit excellent stability, reduced aggregation, and enhanced 
fluorescence in borate buffer.  
In spite of the benefits of staining in borate buffer, elevated pH may be especially 
detrimental to enzymatic activity. Enzymatic activity generally exhibits a bell-shape 
dependence on temperature, with peak activity at an optimal pH specific to the enzyme 
[174]. Therefore, we sought to investigate for ourselves whether borate buffer would 
adversely affect the cellular staining specificity of TMR ligand. Figure 5.4 shows a 
comparison of cells stained with TMR ligand in borate buffer supplemented with 215 
mM sucrose versus standard phenol red-free media. We found that borate buffer was 
effective in reducing nonspecific binding of TMR ligand to native U2OS cells (denoted 
HTP-) when compared to staining in cellular media. Borate buffer only slightly reduced 
specific binding of TMR ligand to U2OS-ECS1-HTP cells (denoted HTP+), resulting in a 
little decreased fluorescence staining intensity. However, we found that cells were unable 
to tolerate elevated pH conditions for extended time without changes in morphology, so 




Figure 5.4. Effect of pH on TMR ligand staining of HaloTag protein expressing (HTP+) 
cells and control (HTP-) cells. Cells are either stained in cellular media (pH 7.4) or borate 
buffer supplemented with 215 mM sucrose (pH 8.5). Staining is performed at 4 
0
C to 
illustrate the effects of pH on nonspecific binding. (a) Specific staining of HTP+ cells at 
different pHs is shown over a constant dynamic range of 7000 units. (c) Nonspecific 
staining of HTP- cells at different pHs is shown over a constant dynamic range of 100 
units. Elevated pH results in decreased nonspecific binding to HTP- cells and only 




Through our cell staining experiments with TMR ligand, we were able to 
optimize the staining conditions needed for QD-HTL staining of HTP expressing cells. 
Many of the same effects observed for TMR staining were also reflected with QD-HTL 
staining. For example, lowered temperature was found to exacerbate nonspecific binding 
of both TMR ligand and pegylated QD-HTLs. In this manner, the TMR staining 
experiments served as a positive control for our QD-HTL staining experiments. Upon 
successful optimization of the cell staining conditions, we directed our focus towards 
optimizing the QD surface parameters needed to achieve specific staining.  
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Effect of Ligand Density on Cellular Binding Specificity of Quantum Dot-HaloTag 
Ligand Conjugates 
In the only work to date that has been published on quantum dot-HaloTag 
mediated cell staining, So and coworkers were only able to achieve specific labeling of 
surface HTP with QD conjugates of high ligand density—ideally, at least 50 HaloTag 
ligands per QD. They stated that QD conjugates with as many as 5 HTLs per QD 
displayed virtually no fluorescence in comparison with control QDs lacking HTL [125]. 
While So’s preliminary results seemed discouraging for single-molecule imaging, 
we sought to systematically investigate for ourselves the dependency of specific binding 
on valency for two reasons. First, So’s work did not examine the effects of different 
concentrations on specific staining for each valency. Naturally, QDs of lower ligand 
density would be expected to require higher staining concentrations than QDs of higher 
ligand density to achieve a similar staining intensity. Thus, it is possible that specific 
staining could be achieved with monovalent QD-HTLs if higher concentrations are 
employed. Secondly, So’s work did not investigate staining specificity of QD-HTLs with 
regard to cells lacking HaloTag protein. This is an especially important control for single-
molecule imaging, as it is imperative to know that QD-HTLs are not unintentionally 
tracking random, unwanted proteins.  
We started our cell staining studies with PEG-QD-HTL conjugates containing 
high surface ligand density. Like So, we observed that PEG-QD-HTLs with high ligand 
density exhibited excellent cellular staining specificity in comparison to control PEG-
QDs lacking HTLs. Unfortunately, a major problem was that these PEG-QD-HTLs 
labeled non-HTP expressing cells just as well as cells expressing HTP, such that staining 
 97 
was not truly specific. Through systematic optimization of the staining parameters, we 
discovered QD ligand density to be a key mediator of HaloTag binding specificity.  
As shown in Figure 5.5, no specific binding was observed for multivalent PEG-
QD-HTLs (20:1, 4:1 HTL:QD molar reaction ratios) regardless of the staining 
concentration used. As the surface ligand density was decreased, the degree of 
nonspecific binding likewise decreased, such that staining contrast could finally be 
detected between HTP+ and control HTP- cells. In fact, specific staining was only 
observed for very low ligand densities (2:1, 1:1 HTL:QD molar reaction ratios). Our 
hypothesis is that nonspecifically bound PEG-QD-HTLs of higher valency exhibit much 
slower dissociation rates than PEG-QD-HTLs of low valency due to an increased number 
of nonspecific interactions between the HTL and cell surface proteins. These nonspecific 
interactions are likely mediated between the 6-carbon chain of the HTL and any 
hydrophobic proteins on the cell surface. Thus, while nonspecifically bound monovalent 
PEG-QD-HTLs are able to freely dissociate, it becomes increasingly difficult, if not 
effectively impossible, for nonspecifically bound PEG-QD-HTLs of higher valency to be 














Figure 5.5. Effect of QD surface ligand density on the cell staining specificity of PEG-
QD-HTLs. PEG-QD-HTLs with varying ligand densities (reflected by the HTL:QD 
molar ratio) are incubated with HaloTag protein expressing (HTP+) cells or control 
(HTP-) cells lacking HaloTag protein. Cells are stained with PEG-QD-HTL at (from left 
to right) 1:1, 2:1, 4:1, and 20:1 HTL:QD molar reaction ratio. All PEG-QD-HTLs are 





Effect of PEG Length on Cellular Binding Specificity of Quantum Dot-HaloTag 
Ligand Conjugates  
While valency plays a key role in staining specificity, it is not the sole factor. Our 
studies have shown that the length of PEG used to coat the QD surface is also critically 
important. As shown in Figure 5.6, we found that longer PEG lengths are more effective 
at reducing nonspecific binding of QD-HTL conjugates but are also capable of 
obstructing specific binding. When 2500 MW HTLs were reacted with QDs at a 1:1 
molar ratio and coated with 2000 MW PEG, the resulting PEG-QD-HTLs exhibited very 
little binding to cells, either specific or nonspecific. As the PEG length was shortened to 
1000 MW, specific binding was restored. As the PEG length was further decreased to 370 
MW, the amount of nonspecific binding increased as the shorter PEG is less effective at 
preventing nonspecific binding. These results suggest that the HaloTag ligand may 
become buried in brush-like surface coatings that are too thick. It is also possible that 
QD-HTLs containing 2500 MW ligands experience more binding steric hindrance when 
coated with 2000 MW PEG when compared to smaller molecular weight PEGs. Although 
previous studies showed that QD-HTLs containing 2500 MW ligands are able to bind 
purified HTP when coated with 2000 MW PEG, (Figure 4.11) they may be unable to bind 
cellular HTP as effectively since binding interactions are more sterically hindered when 
constrained to a 2-D surface rather than a 3-D volume. In summary, these results suggest 










































Figure 5.6. Effect of PEG length on the cell staining specificity of PEG-QD-HTLs. PEG-
QD-HTLs coated using different PEG lengths are incubated with HaloTag protein 
expressing (HTP+) cells or control (HTP-) cells lacking HaloTag protein. Cells are 
stained with (left to right) QD-HTL coated using 28,000 molar excess 370 MW PEG; 
QD-HTL coated using 10,000 excess 1000 MW PEG; and QD-HTL coated using 5000 
excess 2000 MW PEG. All PEG-QD-HTLs are prepared with 2500 MW HTL using a 
molar reaction ratio of 1:1 HTL:QD. Scale bar = 40 µm. 
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Staining Specificity of Pegylated Quantum Dot-HaloTag Ligand Conjugates 
Together, our results suggested that QD-HTLs coated with 1000 MW PEG 
containing a low surface ligand valency were ideal for achieving cellular binding 
specificity. Figure 5.7 shows that these PEG-QD-HTL conjugates were able to 
successfully stain HTP expressing cells with respect to cells lacking HaloTag protein. 
Furthermore, pegylated QDs lacking HaloTag ligand exhibited very little nonspecific 






Figure 5.7. Staining specificity of PEG-QD-HTL conjugates to HaloTag protein 
expressing (HTP+) cells with respect to control (HTP-) cells and PEG-QDs lacking 
HaloTag ligand. Both PEG-QDs and PEG-QD-HTLs are coated with 10,000 excess of 
1000 MW PEG. PEG-QD-HTLs of low surface ligand density are prepared using a 2:1 







Four Types of Binding 
The results of our studies regarding interactions between QD-HTLs and cells can 
best be summarized into four different types of binding (Figure 5.8). The goal of our 
staining is to achieve “specific covalent binding” (Figure 5.8, far left). Unlike affinity 
based QD-ligand systems, QD-HTL binding to HTP is covalent and will never dissociate. 
An important corollary is that binding of QD-HTL to HTP cannot be washed out, while 
all nonspecifically bound QD-HTLs can be washed out—at least in theory, if not in 
practice. Thus, greatest efforts to eliminate nonspecific binding should focus on 




Figure 5.8. Summary of the four types of binding of quantum dot-HaloTag ligand 





Nonspecific binding can either be QD-mediated or ligand-mediated. If the QD-
HTL is either uncoated or covered with a thin coating, then QD-mediated nonspecific 
multivalent binding is dominant (Figure 5.8, far right). An uncoated QD essentially 
contains an infinite number of binding sites; consequently, it is virtually impossible to 
wash out uncoated, nonspecifically bound QDs from cells. On the other hand, if the QD 
surface coating is adequately thick, then most of the nonspecific binding will be ligand-
mediated. 
 Just as multivalent interactions can increase the effective on-rate of binding (i.e. 
through “avidity”), we have found that multivalent interactions can also decrease the 
effective off-rate of binding. For instance, if the probability of dissociation for a 
nonspecifically bound HTL is 50%, then the probability of dissociation for a 
nonspecifically bound monovalent QD-HTL is also 50%. However, the probability of 
dissociation for a multivalent QD-HTL containing three nonspecifically bound ligands 
would only be 12.5%. For the HaloTag system, monovalent QD-HTLs can be removed 
with repeated washing, whereas multivalent QD-HTLs cannot. Even QDs with two 
ligands on the surface can function effectively as “monovalent” probes if the ligands are 
well-spaced (Figure 5.8, center right). This phenomenon may account for the dramatic 
increase in nonspecific binding for QD-HTLs prepared with a 4:1 HTL:QD ratio as 
compared to QD-HTLs prepared with a 2:1 HTL:QD ratio, as shown in Figure 5.5. 
5.4 Conclusions 
In this study, we have optimized the labeling conditions to achieve specific 
cellular staining with Quantum Dot-HaloTag ligand probes. We have found that HaloTag 
ligand binding to cellular HaloTag protein is robust, able to withstand changes in staining 
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concentration, temperature, and even slight changes in pH. We further discover that 
staining at 37 
0
C is better than staining at 4 
0
C for reducing nonspecific binding of 
HaloTag probes.    
Two especially interesting observations emerged from our studies of the 
interactions of Quantum Dot-HaloTag ligand probes with cellular surfaces. First, we 
found that low molecular weight ligands can become buried in nanoparticle surface 
coatings that are too thick, decreasing the effectiveness of binding. Second, we found that 
a low nanoparticle surface ligand density close to monovalency is essential for achieving 
specific HaloTag binding.  
Monovalency has long been regarded as essential for single-molecule imaging as 
multivalent probes can crosslink receptors, prohibiting the imaging of single proteins [10, 
12]. Our study now shows that monovalent systems may confer additional benefits such 
as reduced nonspecific binding.  
Importantly, this work presents a clear example where increased surface ligand 
density can cause increased nonspecific binding. Due to their large surface area to 
volume ratio, nanoparticles are capable of presenting multiple surface ligands to target 
cells of interest with high avidity. Because of this “multivalency effect,” nanoparticles 
have long been promoted as excellent carriers for targeted drug delivery and imaging 
[175-178]. However, just as multivalent ligands can increase the avidity of specific 
binding, they can also increase the avidity of nonspecific binding, such that specific 
targeting is no longer achieved. Since the effectiveness of the nanocarrier will largely 
depend on the properties of the receptor-ligand system employed, our results challenge 
researchers to make careful choices when designing multivalent nanocarrier systems. 
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This work presents one of the first illustrative examples of the effect of 
multivalency on nonspecific binding. It highlights the fundamental importance of 
carefully considering both kinetics and surface chemistry in nanoparticle ligand based 
probe designs. These considerations will help guide the design of next-generation 
nanoparticle-based imaging agents for visualization of cellular and biomolecular 























QUANTUM DOT-HALOTAG LIGAND CONJUGATES FOR 
DYNAMIC IMAGING OF CELLULAR PROTEINS 
 
6.1 Introduction 
The commercialization of QD technology has greatly facilitated the widespread 
adoption of QDs into many fields of biomedical research, ranging from in vivo imaging 
to multiplexed disease detection [13]. Single-molecule imaging is one such field that has 
greatly benefited from the accessibility of commercial QDs. Nonetheless, the growing 
consensus is that commercial QDs are becoming increasingly limited in utility due to 
their large size and multivalency. Large QDs are unable to access confined areas of the 
cell, and multivalent QDs pose problems with receptor crosslinking. As our studies have 
shown, multivalent QDs may also exhibit increased propensity for nonspecific binding 
compared to their monovalent counterparts. Indeed, the development of high-quality QD 
imaging probes that are small and monovalent would generate a marked improvement 
over the current state-of-the-art technology, paving the way for future advances in 
cellular imaging [173].  
Thus far, only a few studies integrating the use of size-minimized tagging 
strategies with size-minimized QDs for single-molecule imaging have been published. 
For example, Howarth et al. used dihydrolipoic acid QDs in conjunction with enzymatic 
BirA labeling to track glutamate receptors in hippocampal neurons [10]. Roullier and 
coworkers used gallate-PEG coated QD-Ni
2+
-Tris-nitrilotriacetic acid conjugates to track 
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his-tagged interferon receptors [93]. The majority of these studies have been performed 
using noncovalent techniques that are incompatible with intracellular labeling.  
Our study seeks to optimize the imaging parameters needed such that multidentate 
polymer coated QD-HaloTag ligands can become a viable alternative to the probes used 
in these studies. Such an alternative would prove especially useful in multi-color tracking 
experiments, in which different tagging strategies are needed to label each different type 
of protein. Additionally, our QD-HTL conjugates can potentially be used for intracellular 
imaging. We hope these initial optimization studies with cell surface proteins will help 
pave the way for the full potential of QD-HTLs to be achieved in the future, such that 
QD-HTLs can one day also be used for intracellular single-molecule imaging.  
We have already demonstrated in previous chapters that small, monovalent QD-
HTL conjugates can successfully bind target HaloTag proteins in cells and in solution. 
We now seek to evaluate their performance when applied to single-molecule imaging of 
cell surface proteins. 
6.2 Materials and Methods 
Quantum Dot-HaloTag Ligand Functionalization 
To produce monovalent probes, quantum dots with a very low degree of HaloTag 
functionalization were prepared. Based on the estimate of actual number of ligands per 
QD for a given molar reaction ratio (Chapter 4), QD-HTL conjugates were prepared at a 
0.5:1 HTL:QD molar reaction ratio. All QD-HTL probes were prepared with 2500 MW 
HaloTag ligands and subsequently coated with 10,000 excess 1000 MW PEG and 7,500 
excess EDC according to the procedure described in Chapter 4.   
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Widefield Epifluorescence Microscopy 
Cells were imaged on an Olympus IX71 epifluorescence inverted microscope 
equipped with a Hamamatsu C9100 EM-CCD camera using a 100x objective. All 
samples were illuminated using a mercury arc lamp. The following filters were used for 
visualization of QDs (629 emission): 480/40 excitation, 625/20 emission, 500 dichroic. 
Images were streamed continuously to a computer hard disk with exposure times ranging 
from 50-150 ms. For single-molecule imaging, a longer excitation wavelength (480/40) 
was chosen in comparison to the UV excitation used for ensemble imaging (335-380), as 
UV excitation has been attributed to increased blinking of QDs and higher 
autofluorescence compared to longer wavelengths [172, 173].  
Total Internal Reflection Microscopy 
Single molecule tracking of fluorescent dyes was performed using a TIRFM setup 
to enhance the signal-to-noise ratio (SNR) and reduce the effects of photobleaching 
during imaging. The TIRFM setup consists of an Olympus IX71 inverted microscope 
equipped with a 60x TIRFM objective and Hamamatsu C10600-10B CCD camera. TMR 
ligand (555 excitation, 585 emission) was illuminated using a 561 yellow green laser line 
and visualized with a standard TRITC emission filter (565-605).  
Identification of Single Fluorophores and Single Fluorophore Tracking Analysis 
Single fluorescent dyes were identified by their single-step photobleaching [7, 
179]. Single quantum dots were identified from their blinking intermittency [78]. 
Fluorophore intensity analysis was performed using the MacBiophotonics plugin for 
ImageJ (McMaster University, Canada) [180]. Tracking software was modified from the 
open-source “Object Tracking Software” available from the Rowland Institute at Harvard 
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as described in detail in the Results and Discussion section [181]. When necessary, 
manual tracking was performed using the Manual Tracking plugin for ImageJ developed 
by Fabrice P. Cordelières (Institut Curie, France) to confirm the results of the automatic 
tracking algorithm [182].  
6.3 Results and Discussion 
Selection of Microscope Excitation and Emission Wavelengths 
Due to their large extinction coefficients and absorption cross-sectional areas, 
QDs can be visualized on a standard epifluorescence microscope without need for special 
optical setups such as TIRF microscopy to enhance the signal-to-noise ratio. Nonetheless, 
to visualize single quantum dot trajectories, careful attention should be placed on 
optimizing the microscope settings and recording parameters. In general, widefield 
epifluorescence microscopy is preferred for single QD tracking over confocal microscopy 
due to the reduction in incident light caused by the confocal pinhole aperture [173]. We 
were able to visualize single QDs on a standard Olympus IX71 inverted epifluorescence 
microscope equipped with a highly sensitive EM-CCD camera and a mercury arc lamp. 
QDs with 629 nm emission were selected for the single-molecule imaging studies 
since cellular autofluorescence is reduced in the red spectral region (600-700 nm) [173, 
183]. Since the QD extinction coefficient increases at higher energy, shorter excitation 
wavelengths result in higher QD signal intensity, and UV excitation is often chosen to 
maximize signal output. Unfortunately, we found that UV excitation (335-380 nm) 
resulted in high cellular autofluorescence and greater cytotoxicity. Exciting at a slightly 
higher wavelength window, 440 – 520 nm, was found to be ideal, resulting in minimal 
cell death and reduced autofluorescence while still producing a high QD signal to 
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background ratio. Single QDs could be visualized using a 100x oil immersion objective 
with a 1.4 numerical aperture. 
Cellular Staining Optimization 
In order to accurately reconstruct the QD trajectories, staining must be performed 
at low density to avoid overlap of trajectories. We incubated cells with 0.2 nM QD 
conjugates for 2 minutes, and then performed five quick washes before recording 
trajectories on the microscope. Staining and imaging were performed as quickly as 
possible to minimize internalization of QD conjugates into cells. Since QDs should be 
monovalent to avoid crosslinking of receptors, QDs were functionalized with HTL at a 
0.5:1 HTL to QD ratio. Under these conditions, Figure 6.1 shows that pegylated QD-HTL 
conjugates were able to specifically stain cells expressing a β1 integrin-HTP fusion with 



















Figure 6.1. Staining specificity of PEG-QD-HTL conjugates to β1 integrin-HaloTag 
protein (HTP+) expressing cells at low staining density with respect to control (HTP-) 
cells and PEG-QDs lacking HaloTag ligand. Both PEG-QDs and PEG-QD-HTLs are 
coated with 10,000 excess of 1000 MW PEG. PEG-QD-HTLs are prepared using a 0.5:1 




Quantum Dot Tracking Approaches and Limitations 
Single QDs can be recognized by their signature blinking pattern, while QD 
aggregates do not blink [78]. This blinking process occurs essentially randomly, and 
involves transient moments when the QD fluorescence disappears (“off state”) and 
quickly re-appears (“on state”). While QD blinking offers a facile method for identifying 
single QDs, it poses a logistical challenge for reconstructing QD trajectories. Because of 
QD blinking, it is also impossible to distinguish between QDs diffusing out of the focal 
plane and QDs simply in their off state.  
The easiest method for tracking QDs while accounting for blinking is to perform 
manual tracking. In this method, the user clicks on the fluorescent spot corresponding to 
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the QD trajectory of interest through successive frames using a mouse cursor. Manual 
tracking allows the user to pick out desired QDs from aggregates, and allows the user to 
easily piece together tracks before and after each blink. However, manual analysis is 
extremely low throughput and may be subject to potential experimenter bias.  
In previous years, a few algorithms have been developed that are able to piece 
together QD trajectories before and after each blink [184-188]. For example, Bonneau 
and coworkers developed an elegant algorithm for tracking QDs based on perceptual 
grouping of minimal paths in a 3-D volume (Figure 6.2). In their approach, QD 
trajectories are recorded and exported as a time series of 2-D images, each encoding the 
(x, y)-position of the QDs. The algorithm creates a 3-D volume of these frames with time 
as the third axis. In each frame, QDs are automatically detected and located by using 
Gaussian fitting of the intensity profile to identify fluorescent spots. Lastly, 
correspondence between spots is established by identifying the nearest neighbor spot 


























Figure 6.2. Example of an automatic QD tracking algorithm. First, QD trajectories are 
acquired as a series of 2-D images and arranged into a 3-D volume using time as the third 
axis. Second, QDs are automatically localized using Gaussian fitting of the point spread 
function (PSF) intensity profile. Finally, spots from each frame are connected by linking 
the centers of nearest-neighbor fluorescent spots across adjacent frames. The localization 
accuracy σ of the QD is a function of λ, the QD’s emission wavelength and N, the total 




This example also illustrates some of the limitations inherent to automatic 
tracking algorithms. Since QDs are automatically detected by the software, it may be 
difficult to distinguish between desired QD trajectories and undesired trajectories. In 
general, the software will indiscriminately detect and track all spots in a given image, 
whether on the cell, in solution, or immobilized on the glass slide—in focus or out of 
focus. Consequently, special care must be taken to ensure that all detected spots are 
indeed on the cell surface in the proper focal plane. With automatic detection, it is also 
virtually impossible to distinguish between spots corresponding to single QDs and spots 
corresponding to QD aggregates. Because large aggregates are often less mobile or 
immobile, the calculated average diffusion coefficient may be lower than actual when 
aggregates are present. Another limitation is that these algorithms generally rely on the 
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assumption that the distance between two different QDs is larger than then diffusion 
distance of each individual QD. While this is generally true when the staining density is 
low, a possibility exists that the algorithm may fail to correctly piece together trajectories 
of extremely fast-diffusing QDs. In summary, automatic tracking algorithms offer the 
advantage of being able to process large populations of QDs for long periods of time. 
However, possible inaccuracies that may arise from the automation process must be taken 
into consideration. Trajectories analyzed using automatic tracking algorithms should be 
carefully reviewed to ensure they accurately reflect desired QD labeled proteins of 
interest. To date, the number of commercially available or freely downloadable 
algorithms that account for QD blinking still remain limited. 
In our study, we sought to combine the best of both worlds of automatic and 
manual tracking by implementing a semi-automatic tracking procedure. While 
populations of particles were automatically tracked, we manually pieced together 
interrupted trajectories between blinks. We also manually isolated desired trajectories in 
order to ensure QDs were located on the cell surface and that aggregates were excluded 
from analysis.  
Quantum Dot Tracking Algorithm 
We adapted our tracking algorithm from the open-source “Object Tracking 
Software” available from the Rowland Institute at Harvard [181]. We chose this software 
primarily because of its open-source nature and its Matlab runtime environment, which 
would allow us to easily make modifications to the software code when needed. An 
image sequence is first converted into a stack of 2-D images and uploaded into the 
software. The general algorithm can be summarized into the following basic steps:  
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1. Retrieve an image frame. 
2. Define an intensity threshold for each particle in the frame. 
3. Locate the center of each particle. 
4. Define a circle with distance cutoff radius, “R” = the maximum distance a particle 
can move from one frame to the next. 
– If 1 particle is in the circle, continue tracking 
– If 2 or more particles are in the circle, retire old track, start 2+ new tracks 
– If 0 particles are in the circle, retire old track  
5. Complete tracking.   
6. Isolate tracks of interest and/or delete unwanted tracks. 
7. Piece together interrupted tracks. 
8. Output coordinate information for further analysis.    
9. Compute the mean squared displacement and diffusion coefficient.  
 
Several alterations were made to the original open source software. For instance, 
we modified the program to output track coordinates into Microsoft Excel, where tracks 
could be reviewed. At this point, tracks that did not reflect blinking QDs were eliminated. 
We wrote additional code that would allow the computation of the mean squared 
displacement (MSD) versus time and the diffusion coefficient from the track data.   
Quantum Dot Tracking Example 
An example of a single QD tracking sequence is shown in the multimedia file 
associated with Figure 6.3. To determine the locations of the QDs, the first step is to 
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define an intensity threshold for detecting the fluorescent spots. This threshold is selected 
as a number from 0 to 255 for an 8-bit grayscale image. As shown in Figure 6.4, if the 
intensity threshold is too low (e.g. set at “30”), the tracking algorithm picks up too much 
noise. If the threshold is too high (e.g. set at “70”), the tracking algorithm fails to detect 
several QDs, and instead primarily detects aggregates, which often appear brighter than 







Figure 6.3. Single-molecule tracking of cell surface β1 integrin-HTPs labeled with PEG-
QD-HTL conjugates (wen_mary_m_201308_phd_fig63_qdtracking.avi). Images were 
streamed continuously using an exposure time of 150 ms. Movie sequence is shown at 7 




The next step is to define the distance cutoff radius, “R,” as the maximum 
distance in pixels a QD can travel from one frame to the next. Figure 6.5 shows 
histograms of all single-frame displacements, also known as the distance traveled by each 
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QD within a particular frame, up to each given value of “R”. When the R value is too low 
(e.g. R = 1), the histogram abruptly terminates at the designated R value. The fact that the 
histogram never smoothly “levels off” at R =1 suggests that several displacements greater 
than 1 pixel exist in reality. When the R value is too high (e.g. R = 25), the search radius 
starts to pick up other QDs in the vicinity. An R value of 6 pixels was found to be 
reasonable for our example. Due to the presence of immobilized aggregates that have not 
yet been filtered out at this stage in the tracking process, many QDs exhibit very low 


















Figure 6.4. Setting the intensity threshold for identification of quantum dots in the 
tracking procedure. For an 8-bit grayscale image, the intensity threshold is given as a 





Figure 6.5. Setting the distance-cutoff radius “R,” also known as the maximum distance 




Upon successful optimization of the intensity threshold and distance cutoff radius, 
tracking can be performed. Figure 6.6 shows the tracking results for our example, along 
with the subsequent processes of deleting unwanted tracks and manually piecing together 




















For each trajectory (x(t), y(t)), the mean squared displacement can be calculated 





where N is the total number of frames, τ is the acquisition time, and time t = nτ [172, 173, 
189]. Once the MSD vs. time plot has been established, the diffusion coefficient (D) can 
be determined by fitting the first four points of the curve using the following equation:  
MSD (nτ) = 4Dnτ + b    Equation 6.2 
 
The type of motion exhibited by the QD trajectory can be determined by examining the 
shape of the curve [190-192]. When b = 0, the QD exhibits normal Brownian diffusion: 
Normal diffusion MSD (nτ) = 4Dnτ    Equation 6.3 
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When directed motion with velocity v is present, as in the case of active transport with 
molecular motors, the MSD curve can be described as follows: 






    Equation 6.4 
 
Finally, when the trajectory undergoes diffusion in a confined area, the MSD curve 
approaches a horizontal asymptote of value L: 
Confined diffusion     _ Equation 6.5 
 
The shape of the MSD versus time curves for different types of diffusion is depicted in 














Figure 6.7. Different types of single-molecule motion as classified by the mean squared 
displacement. Single molecules may exhibit Brownian diffusion (green), confined 
diffusion (blue), or directed motion via active transport (red). Adapted from [173].   
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Diffusion Characteristics of Quantum Dot-HaloTag Ligand Labeled β1 Integrin- 
HaloTag Proteins 
Figure 6.8 shows examples of some MSD curves calculated for the PEG-QD-HTL 
labeled β1 integrin-HTPs diffusing on the cell surface. The vast majority of the proteins 
exhibited confined diffusion, with less than 5% exhibiting free diffusion. In this example, 
no evidence of directed motion was found.  
This behavior is consistent with the behavior of β1 integrins described in the 
literature. While tracking the mobility of α5β1 integrins on the surface of fibroblasts 
using polystyrene beads, Hirata and coworkers likewise observed that the vast majority of 






















Figure 6.8. Examples of various mean squared displacement curves over time for cell 




We determined the average diffusion coefficient for β1 integrin-HTPs diffusing 
on the surface of the U2OS-ECS1-HTP cells to be 2.41 x 10
-10





is fairly consistent with the values of diffusion coefficients reported in the literature. 
Using Invitrogen 655 QD-antibody conjugates, Chen and coworkers determined the 
diffusion coefficient of β1 integrins on the surface of human osteoblasts to be in the range 




/s [28]. Using fluorescence recovery after photobleaching (FRAP) to 
study β1 integrin mobility, Duband and coworkers determined the range of diffusion 
coefficients to fall within 2 x 10
-10 




/s [194]. Virtually all of these 
studies reported a broad distribution of diffusion coefficients for β1 integrin movement. 
For example Hirata et al. observed a 15-fold difference between their lowest and highest 




/s for some integrins [193].  
Comparison of β1 Integrin-HaloTag Proteins Labeled with Quantum Dot-HaloTag 
Ligands versus TMR Ligands  
The above results show that the activity of β1 integrin-HTPs labeled with QD-
HTLs is consistent with the activity of β1 integrin reported in the literature, as measured 
using a wide variety of different techniques. To see if differences in labeling probe would 
affect integrin activity, we sought also to evaluate the activity of β1 integrin-HTPs 
labeled with QD-HTLs with respect to β1 integrin-HTPs labeled with TMR ligand.  
Figure 6.9 shows the difference between HTP-β1 integrins tracked using PEG-
QD-HTLs versus TMR ligand using widefield microscopy. This figure highlights the 
inherent challenges of performing single-molecule imaging with fluorescent dyes with 
standard epifluorescence microscopy. Even when TMR ligand, the brightest 
commercially available dye-HaloTag ligand conjugate, was used, the signal-to-noise ratio 
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was so low that the image sequences could neither be tracked automatically or manually 
(Figure 6.9b).  Instead, total internal reflectance microscopy (TIRFM) was needed to 







Figure 6.9. Comparison of single-molecule tracking of cell surface β1 integrin-HTPs 
labeled with PEG-QD-HTLs versus TMR ligands using widefield microscopy. (a) β1 
integrin-HTPs labeled with PEG-QD-HTLs 
(wen_mary_m_201308_phd_fig69a_qdtracking.avi). (b) β1 integrin-HTPs labeled with 
TMR ligand (wen_mary_m_201308_phd_fig69b_tmrtracking.avi). Movie sequences are 
shown at the same dynamic range, same frame rate (7 fps), and same exposure time (150 






Figure 6.10. Single-molecule tracking of cell surface β1 integrin-HTPs labeled with 
TMR ligands using total internal reflectance microscopy 
(wen_mary_m_201308_phd_fig610_tmrtirf.avi). In this example, images were streamed 
continuously using an exposure time of 500 ms. Movie sequence is shown at 2 frames per 




Figure 6.11 shows the results of our study comparing the distributions of PEG-
QD-HTL vs. TMR-ligand labeled β1 integrin-HTPs. The mean diffusion coefficients for 









/s, respectively. The median diffusion coefficient for 




/s, while the median diffusion 




/s. The diffusion 
coefficient values for β1 integrin-HTPs labeled with PEG-QD-HTL and TMR ligand 
were found not to be significantly different according to the Mann Whitney U Test 
(p>0.05). Together, these results indicate that the QD-HTL label does not drastically alter 
























Figure 6.11. Box plots comparing diffusion coefficients of β1 integrin-HTPs labeled with 
pegylated QD-HTLs and TMR ligands. The median is denoted by a horizontal solid line 
(—) while the mean is denoted by a horizontal dotted line (---). Upper and lower box 




 percentiles, while the whiskers above and below the 









In this chapter we have shown that QD-HTL conjugates can be used for single-
molecule imaging of cell surface proteins. We have developed a semi-automatic tracking 
algorithm that allows us to automatically track proteins labeled with QDs while manually 
identifying tracks of interest. We show that QD-HTLs exhibit enhanced signal-to-noise 
ratio and greater resistance to photobleaching when compared to fluorescent dyes, 
allowing facile tracking of single proteins on a standard epifluorescence microscope. 
Importantly, we demonstrate that the behavior of cell surface β1 integrin-HaloTag fusion 
proteins labeled with QD-HTLs exhibit behavior that is similar to the behavior of β1 
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integrins reported in the literature. These QD-HTL labeled β1 integrin-HaloTag fusion 
proteins exhibit similar diffusion coefficients and confined diffusion behavior as native 
β1 integrins, as reported in the literature using a wide variety of techniques including 
bead labeling and fluorescence recovery after photobleaching. Altogether, these results 
demonstrate that size minimized quantum dot-HaloTag ligand conjugates are a promising 
new technology for visualizing single molecules in live cells at high resolution.  
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CHAPTER 7 
SUMMARY AND FUTURE DIRECTIONS 
 
7.1 Summary 
The goal of this dissertation, as outlined in Chapter 1, was to develop new tagging 
strategies that better enable quantum dots to be used for tracking receptors in dynamic 
live cell imaging. In Chapter 2, we discussed the advantages of quantum dots over 
fluorescent dyes for live cell imaging, especially single-molecule imaging. We also 
discussed some of the major limitations of current QD probes and how the next 
generation of QD probes should be improved to better facilitate imaging.  
In Chapter 3, we specifically focused on improvements that can be made in 
reducing the size of current QDs and in improving their targeting strategies. We 
identified HaloTagging as a potential strategy that would meet both the demand of 
reducing QD probe size while offering improved binding characteristics to target 
receptors. We proposed that low molecular HaloTag ligands could be grafted onto the 
surface of size-minimized QDs, and that the resulting conjugates could be used to 
covalently bind and track cellular receptors genetically fused to a HaloTag protein.  
In Chapters 4 through 6, we sought to develop the proposed quantum dot-
HaloTag ligand conjugates and to test their binding to cellular proteins before applying 
them to the single molecule tracking of cellular receptors. The first purpose of Chapter 4 
was to develop a synthesis procedure for reacting HaloTag ligands with compact 
multidentate-polymer coated QDs to produce size-minimized QD-HTL conjugates. The 
second purpose was to optimize the QD surface chemistry needed to achieve specific 
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binding between QD-HTL conjugates and purified HaloTag proteins in solution. Several 
variables were investigated including the length of the HaloTag ligand, the number of 
HTLs on the surface, and the amount of PEG coverage needed to reduce nonspecific 
binding. Our results showed that longer HaloTag ligands bind more effectively to target 
proteins compared to shorter ligands when coupled to nanoparticle surfaces. One 
promising observation was that QDs displaying a low density of surface ligands were 
able to bind target protein just as effectively as QDs displaying a high surface ligand 
density. While addition of PEG molecules to the surface coating helped to reduce 
nonspecific binding, excessive PEG was found to obscure HaloTag ligand binding, 
thereby proving that a careful balance was needed to achieve specific binding.  
The focus of Chapter 5 was to optimize the conditions needed to achieve specific 
binding between QD-HTL conjugates and cells expressing HaloTag proteins. Several 
major trends observed in Chapter 4 regarding binding to soluble proteins were again 
mirrored with binding to cellular protein. As shown in Chapter 4, PEG was needed to 
prevent nonspecific binding to cells, but excessive PEG could block specific HaloTag 
binding. This was especially manifest when longer PEG lengths, which could easily bury 
the ligand, were used. Again, QDs with low surface ligand density were found to bind 
cellular HaloTag protein just as well as QDs containing a high ligand density. In Chapter 
5, however, an important new observation emerged: QDs containing a high surface ligand 
density were found to exhibit higher nonspecific binding to cells than those containing 
low surface ligand density. In fact, only QDs with very low ligand densities near 
monovalency were found to exhibit specific staining of HaloTag protein expressing cells 
with respect to controls. 
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One important theme that has resounded throughout this thesis is the delicate 
balance between specific and nonspecific binding. This fine interplay is strongly 
mediated by the QD surface parameters, including ligand length, ligand valency, PEG 
length and PEG density. In Chapter 5, we were able to strike an appropriate balance 
among these variables to create QD-HTLs capable of specifically labeling β1 integrin-
HaloTag fusion proteins on cell surfaces.  
Finally, in Chapter 6 we extended these QD-HTL conjugates to the live cell 
imaging of β1 integrin-HaloTag fusion proteins on a single-molecule level. We showed 
that these QD-HTLs exhibit superior performance to fluorescent dyes in terms of 
photostability and signal-to-noise ratio. We also showed that these QD-HTLs convey 
accurate information regarding integrin movements compared to other reported studies. 
This work is significant because it is the first to successfully synthesize size-
minimized QD-HTLs that bind specifically to purified and cellular HTP. It is also the 
first study to utilize these QD-HTLs for dynamic single-molecule imaging of cellular 
proteins. For the first time, we have identified the binding parameters that govern the 
interactions between QD-HTLs and cellular HTP, and we have further shown that 
monovalency is ideal for achieving specific HaloTag binding. Altogether, our results 
show that size-minimized QD-HTLs exhibit promise for use as single-molecule imaging 
probes for dynamic live cell imaging.  
Opportunities now arise for extending the application of the QD-HTL conjugates 
to the detailed investigation of other biological receptors in living cells. Below, we detail 
some of the most exciting opportunities for advancing and applying this quantum dot-
HaloTag technology.  
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7.2 Future Directions 
Intracellular Protein Targeting of Quantum Dot-HaloTag Ligand Conjugates 
Direct QD labeling of intracellular proteins is arguably the most important hurdle 
that must be overcome for QD-tracking to gain widespread utility in live cell imaging 
applications; yet for many reasons, it remains a highly ambitious goal fraught with many 
challenges. One of the most promising hallmarks of the HaloTag labeling strategy is its 
compatibility with intracellular protein labeling. To evaluate whether QD-HTLs can be 
used to directly target intracellular proteins, QD-HTLs would first need to be successfully 
delivered intracellularly and found to be freely diffusing inside the cytoplasm. We have 
already shown that our size-minimized multidentate polymer coated QDs can be 
successfully delivered monodispersely into cell cytoplasms using pinocytic loading 
(Chapter 3). Our studies have also shown that red core-shell QD-HTL conjugates coated 
with 1000 MW PEG are ~12 nm in hydrodynamic diameter (Chapter 4), thus meeting the 
general size requirement for free diffusion on cellular interiors (Chapter 3) [3, 106]. As 
shown in Chapter 4, another promising observation is that these PEG-QD-HTL 
conjugates exhibit minimal nonspecific binding to whole cell lysates.  
One of the fundamental obstacles to intracellular QD targeting is the impossibility 
of removing unbound QDs from intracellular compartments. Since QDs are membrane-
impermeable and cannot be washed out like fluorescent dyes, it is advantageous to pick a 
system in which a hallmark behavior can be used to distinguish QDs that are bound to 
their target from those that are not. For example, Courty and coworkers utilized the 
stepwise processivity of QD-kinesin conjugates to evaluate successful targeting to 
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microtubules. Through their linear directed motions, microtubule-bound QD-kinesins 
could be distinguished from unbound QD-kinesins freely diffusing in the cytoplasm [89].  
Los and coworkers have already developed a model system utilizing the 
TNFα/NF-κB pathway that can potentially be used to evaluate intracellular targeting of 
QD-HTLs. Upon binding of the proinflammatory cytokine TNFα to its receptor, NF-κB, 
is released from cytosolic sequestration and freely moves into the nucleus to induce 
transcription of genes encoding various inflammatory cytokines [195]. NF-κB is a 
heterodimer composed of two subunits, p65 and p50. In a 2008 study performed by Los 
et al. the HaloTag protein was successfully fused to p65 and imaged with TMR ligand 
using traditional ensemble imaging methods. Upon addition of TNFα to the cellular 
medium, the TMR signal could be observed to shift from the cytosol to the nucleus [40].   
The p65-HaloTag fusion is a promising candidate for pilot intracellular QD-
tracking studies. Previous literature reports have consistently indicated that QDs above 3 
nm in size do not spontaneously move into the nucleus [32, 114, 115]. Hence, any 
translocation of QD-HTLs from the cytosol into the nucleus should theoretically be 
mediated by the p65-HaloTag fusion protein. It will be interesting to evaluate the direct 
intracellular targeting capabilities of QD-HTLs on this system and others like it.  
Development of Orthogonal Labeling Strategies for Multiplexed Quantum Dot 
Imaging  
One of the great advantages of QDs is their ability to be easily used in 
multiplexed assays and multi-color tracking experiments [21, 49]. Since all QDs 
intrinsically possess broad absorption bands and narrow emission bands, a single light 
source can be used to concurrently excite multiple QDs with different emission 
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wavelengths. As such, quantum dots of different colors can be used to label different 
proteins and their movements and interactions can be simultaneously tracked [79, 93, 
196]. To facilitate multi-color tracking while yet harnessing the advantages of covalent, 
monovalent labeling, it would be advantageous to develop orthogonal QD labeling 
strategies compatible with the HaloTag technology. One of the most apparent choices for 
an orthogonal labeling strategy would be to use the SNAP-Tag, a 20 kDa mutant form of 
the human DNA repair protein O
6
-alkylguanine-DNA-alkyltransferase (hAGT), which 
reacts covalently with the nucleobase O
6
-benzylguanine (BG) [126]. Like the HaloTag 
strategy, the SNAP-Tag strategy is compatible with intracellular labeling. QDs 
functionalized with BG ligands can bind covalently to cellular target proteins expressing 
a SNAP-Tag fusion in the same manner that QD-HTLs bind to HaloTag fusion proteins. 
One early study has shown that commercial QDs functionalized with BG molecules 
exhibit binding to purified SNAP-Tag proteins in vitro, although the reaction remains to 
be optimized [127]. We expect that many of the parameters used to optimize QD-HTL 
binding to cells would also apply to QD-benzylguanine conjugates.  
Non-Blinking Quantum Dots for Single-Molecule Imaging 
While the hallmark blinking characteristic of QDs facilitates the identification of 
single QDs, it also poses challenges for reconstructing trajectories. When blinking QDs 
are used for cellular imaging, QDs that are in their “off-state” cannot be distinguished 
from QDs transiently diffusing out of the focal plane. As a result, it is especially difficult 
to perform 3-D tracking with blinking QDs [197]. 3-D tracking will become even more 
important for intracellular QD tracking, when diffusion is no longer as localized to a 2-D 
surface as it is with cell membrane diffusion.  
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Because of this, many research groups have set forth efforts to produce non-
blinking QDs. Early studies showed that blinking could be greatly suppressed if very 
thick shells were grown on top of the quantum dot core. Although blinking could not be 
entirely abolished using this method, these thick-shelled QDs were found to be in their 
“on-state” for greater than 97% of the time [198, 199]. Unfortunately, the advantages of 
size-minimization discussed in this thesis are abolished when thick-shelled QDs are used 
(Chapter 3). Thus, while thick-shelled QDs can still be used for tracking membrane 
receptors in unconfined regions of the cell, their widespread applicability in live cell 
imaging remains limited.  
Recently, Wang and coworkers published the first report of entirely non-blinking 
QDs. They found that blinking could be entirely eliminated if core-shell QDs were 
prepared with a smooth composition gradient from the core to the shell. Although this 
mechanism remains poorly understood and somewhat controversial, this work 
demonstrates progress towards producing nonblinking QDs at more compact sizes (<10 
nm in diameter) [200].  
As advances continue to be made in the development of non-blinking QDs, it will 
be interesting to incorporate non-blinking QDs with HaloTagging or other site-specific 
tagging strategies for single-molecule imaging.  
Super-Resolution Live Cell Imaging 
While the advent of QD technology has allowed researchers to visualize dynamic 
cellular events with much greater clarity than previously possible with fluorescent dyes, 
new opportunities now exist for imaging these events at an unprecedented resolution. 
Previously, fluorescence microscopy imaging techniques were limited in spatial 
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resolution to ~200 nm, but the recent emergence of super-resolution imaging has allowed 
researchers to overcome the diffraction limit of light [8].  
Common super-resolution techniques used in cell biology include RESOLFT 
[201], STED [202], PALM [203], FPALM [204], and STORM [205]. Many of these 
techniques require the use of photoswitchable fluorophores in order to produce super-
resolution images.  
For example, the stochastic optical reconstruction microscopy (STORM), 
photoactivated localization microscopy (PALM) and fluorescence photoactivation 
localization microscopy (FPALM) techniques all function by stochastically switching on 
and off individual fluorophores. These techniques rely on the fact that the signal from a 
single fluorophore can be localized at up to 1 nm accuracy if no other fluorophores are 
emitting the same signal within 200 nm of its location [206]. If a photoswitchable 
fluorophore is used to stain a cellular structure, individual fluorophores can be 
stochastically turned on at low density and their positions can be recorded at single-digit 
nanometer accuracy. These fluorophores are then turned off and the process is repeated 
by stochastically activating another set of fluorophores. After numerous repetitions, the 
entire cellular structure can be resolved at single-digit nanometer accuracy [8].  
In these techniques, the maximum spatial resolution achievable is directly 
determined by the photon output of the fluorophore [207]. In this regard, quantum dots 
are potentially great candidates for super-resolution imaging due to their high extinction 
coefficients and large quantum yields. Research in producing photoswitchable QDs has 
already begun. In 2008, Irvine et al. demonstrated that signal from manganese doped 
ZnSe QDs can be reversibly activated and depleted with up to 90% efficiency. The 
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authors were able to image clusters of these QDs in vitro using super-resolution 
RESOLFT imaging [208].  
The possibility of using quantum dots for super-resolution imaging in living cells 
is an exciting frontier to be explored in years to come. In the future, we believe that 
continued improvements in quantum dot probe design will help extend their applicability 
into far-reaching areas of biology and medicine. Meanwhile, the developments presented 
here will help guide the design of next-generation nanoparticle-based imaging probes, 
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